10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

(Mark One)
þ	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the quarterly period ended March 31, 2011
or
o	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the transition period from          to

Commission file number 1-11239

HCA Holdings, Inc.

(Exact name of registrant as specified in its charter)

Delaware	27-3865930
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

One Park Plaza
Nashville, Tennessee
(Address of principal executive offices) 37203
(Zip Code)

(615) 344-9551

(Registrant’s telephone number, including area code)

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes þ     No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes o     No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer o Accelerated filer o Non-accelerated filer þ Smaller reporting company o

(Do not check if a smaller reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes o     No þ

Indicate the number of shares outstanding of each of the issuer’s classes of common stock as of the latest practicable date.

Class of Common Stock	Outstanding at April 30, 2011
Voting common stock, $.01 par value	515,646,400 shares

HCA HOLDINGS, INC.
Form 10-Q
March 31, 2011

			Page of
			Form 10-Q
	Part I.	Financial Information
	Item 1.	Financial Statements (Unaudited):
		Condensed Consolidated Income Statements — for the quarters ended March 31, 2011 and 2010		3
		Condensed Consolidated Balance Sheets — March 31, 2011 and December 31, 2010		4
		Condensed Consolidated Statements of Cash Flows — for the quarters ended March 31, 2011 and 2010		5
		Notes to Condensed Consolidated Financial Statements		6
	Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		26
	Item 3.	Quantitative and Qualitative Disclosures About Market Risk		42
	Item 4.	Controls and Procedures		42
	Part II.	Other Information
	Item 1.	Legal Proceedings		42
	Item 1A.	Risk Factors		43
	Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds		44
	Item 5.	Other Information		45
	Item 6.	Exhibits		45
Signatures				47
EX-10.5
EX-31.1
EX-31.2
EX-32
EX-101 INSTANCE DOCUMENT
EX-101 SCHEMA DOCUMENT
EX-101 CALCULATION LINKBASE DOCUMENT
EX-101 LABELS LINKBASE DOCUMENT
EX-101 PRESENTATION LINKBASE DOCUMENT

2

HCA HOLDINGS, INC.
CONDENSED CONSOLIDATED INCOME STATEMENTS
FOR THE QUARTERS ENDED MARCH 31, 2011 AND 2010
Unaudited

(Dollars in millions, except per share amounts)

	2011			2010
Revenues	$	8,055		$	7,544
Salaries and benefits		3,295			3,072
Supplies		1,275			1,200
Other operating expenses		1,322			1,202
Provision for doubtful accounts		649			564
Equity in earnings of affiliates		(76	)		(68	)
Depreciation and amortization		358			355
Interest expense		533			516
Losses on sales of facilities		1			—
Impairments of long-lived assets		—			18
Termination of management agreement		181			—
		7,538			6,859
Income before income taxes		517			685
Provision for income taxes		183			209
Net income		334			476
Net income attributable to noncontrolling interests		94			88
Net income attributable to HCA Holdings, Inc.	$	240		$	388
Per share data:
Basic earnings per share	$	0.54		$	0.91
Diluted earnings per share	$	0.52		$	0.89
Shares used in earnings per share calculations (in thousands):
Basic		444,202			426,350
Diluted		461,969			435,680

See accompanying notes.

3

HCA HOLDINGS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
Unaudited
(Dollars in millions)

	March 31,			December 31,
	2011			2010
ASSETS
Current assets:
Cash and cash equivalents	$	553		$	411
Accounts receivable, less allowance for doubtful accounts of $3,870 and $3,939		4,060			3,832
Inventories		881			897
Deferred income taxes		916			931
Other		576			848
		6,986			6,919
Property and equipment, at cost		25,855			25,641
Accumulated depreciation		(14,508	)		(14,289	)
		11,347			11,352
Investments of insurance subsidiary		590			642
Investments in and advances to affiliates		852			869
Goodwill		2,705			2,693
Deferred loan costs		354			374
Other		975			1,003
	$	23,809		$	23,852
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current liabilities:
Accounts payable	$	1,348		$	1,537
Accrued salaries		975			895
Other accrued expenses		1,398			1,245
Long-term debt due within one year		546			592
		4,267			4,269
Long-term debt		24,820			27,633
Professional liability risks		1,003			995
Income taxes and other liabilities		1,507			1,608
Equity securities with contingent redemption rights		—			141
Stockholders’ deficit:
Common stock $0.01 par; authorized 1,800,000,000 shares; outstanding 515,614,300 shares in 2011 and 427,458,800 shares in 2010		5			4
Capital in excess of par value		3,057			386
Accumulated other comprehensive loss		(344	)		(428	)
Retained deficit		(11,648	)		(11,888	)
Stockholders’ deficit attributable to HCA Holdings, Inc.		(8,930	)		(11,926	)
Noncontrolling interests		1,142			1,132
		(7,788	)		(10,794	)
	$	23,809		$	23,852

See accompanying notes.

4

HCA HOLDINGS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE QUARTERS ENDED MARCH 31, 2011 AND 2010
Unaudited
(Dollars in millions)

	2011			2010
Cash flows from operating activities:
Net income	$	334		$	476
Adjustments to reconcile net income to net cash provided by operating activities:
Changes in operating assets and liabilities		(774	)		(838	)
Provision for doubtful accounts		649			564
Depreciation and amortization		358			355
Income taxes		321			238
Losses on sales of facilities		1			—
Impairments of long-lived assets		—			18
Amortization of deferred loan costs		20			20
Share-based compensation		8			8
Other		1			18
Net cash provided by operating activities		918			859
Cash flows from investing activities:
Purchase of property and equipment		(329	)		(214	)
Acquisition of hospitals and health care entities		(22	)		(21	)
Disposition of hospitals and health care entities		55			24
Change in investments		20			29
Other		3			1
Net cash used in investing activities		(273	)		(181	)
Cash flows from financing activities:
Issuance of long-term debt		—			1,387
Net change in revolving credit facilities		(2,604	)		1,339
Repayment of long-term debt		(296	)		(1,510	)
Distributions to noncontrolling interests		(95	)		(83	)
Distributions to stockholders		(30	)		(1,751	)
Payment of debt issuance costs		—			(25	)
Issuance of common stock		2,506			—
Income tax benefits		22			42
Other		(6	)		(1	)
Net cash used in financing activities		(503	)		(602	)
Change in cash and cash equivalents		142			76
Cash and cash equivalents at beginning of period		411			312
Cash and cash equivalents at end of period	$	553		$	388
Interest payments	$	401		$	374
Income tax refunds, net	$	(160	)	$	(71	)

See accompanying notes.

5

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 — INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Reporting Entity

On November 17, 2006, HCA Inc. completed its merger with Hercules Acquisition Corporation, pursuant to which the Company was acquired by Hercules Holding II, LLC, a Delaware limited liability company owned by a private investor group comprised of affiliates of Bain Capital Partners, Kohlberg Kravis Roberts & Co., BAML Capital Partners (formerly Merrill Lynch Global Private Equity) (each a “Sponsor”), affiliates of Citigroup Inc. and Bank of America Corporation (the “Sponsor Assignees”) and affiliates of HCA founder, Dr. Thomas F. Frist Jr., (the “Frist Entities,” and together with the Sponsors and the Sponsor Assignees, the “Investors”) and by members of management and certain other investors.

On November 22, 2010, HCA Inc. reorganized by creating a new holding company structure (the “Corporate Reorganization”). HCA Holdings, Inc. became the new parent company, and HCA Inc. is a wholly-owned direct subsidiary of HCA Holdings, Inc. As part of the Corporate Reorganization, HCA Inc.’s outstanding shares of capital stock were automatically converted, on a share for share basis, into identical shares of our common stock. Immediately following the Corporate Reorganization, our amended and restated certificate of incorporation, amended and restated bylaws, executive officers and board of directors were the same as HCA Inc.’s in effect immediately prior to the Corporate Reorganization, and the rights, privileges and interests of HCA Inc.’s stockholders remained the same with respect to us as the new holding company.

During February 2011, our Board of Directors approved an increase in the number of our authorized shares to 1,800,000,000 shares of common stock and a 4.505-to-one split of our issued and outstanding common shares. All common share and per common share amounts in these condensed consolidated financial statements and notes to condensed consolidated financial statements reflect the 4.505-to-one split. During March 2011, we completed the initial public offering of 87,719,300 shares of our common stock at a price of $30.00 per share (before deducting underwriter discounts, commissions and other related offering expenses). Certain of our stockholders also sold 57,410,700 shares of our common stock in this offering. We did not receive any proceeds from the shares sold by the selling stockholders. Our common stock is now traded on the New York Stock Exchange (symbol “HCA”).

The Investors have provided management and advisory services to the Company pursuant to a management agreement among HCA Inc. and the Investors executed in connection with the Investors’ acquisition of HCA Inc. in November 2006. The management agreement was terminated pursuant to its terms upon completion of the initial public offering of our common stock, and the Company paid the Investors a final fee of $181 million. The management agreement also provided that the Company pay a 1% fee in connection with certain financing, acquisition, divestiture and change of control transactions. The Company paid the Investors a fee of $26 million related to the initial public offering of our common stock, and this fee was recorded as a cost of the stock offering.

HCA Holdings, Inc. is a holding company whose affiliates own and operate hospitals and related health care entities. The term “affiliates” includes direct and indirect subsidiaries of HCA Holdings, Inc. and partnerships and joint ventures in which such subsidiaries are partners. At March 31, 2011, these affiliates owned and operated 156 hospitals, 98 freestanding surgery centers and facilities which provided extensive outpatient and ancillary services. Affiliates of HCA Holdings, Inc. are also partners in joint ventures that own and operate seven hospitals and nine freestanding surgery centers, which are accounted for using the equity method. HCA Holdings, Inc.’s facilities are located in 20 states and England. The terms “Company,” “HCA,” “we,” “our” or “us,” as used herein and unless otherwise stated or indicated by context, refer to HCA Inc. and its affiliates prior to the Corporate Reorganization and to HCA Holdings, Inc. and its affiliates after the Corporate Reorganization. The terms “facilities” or “hospitals” refer to entities owned and operated by affiliates of HCA and the term “employees” refers to employees of affiliates of HCA.

6

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 1 — INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete consolidated financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included and are of a normal and recurring nature.

The majority of our expenses are “cost of revenue” items. Costs that could be classified as general and administrative would include our corporate office costs, which were $54 million and $40 million for the quarters ended March 31, 2011 and 2010, respectively. Operating results for the quarter ended March 31, 2011 are not necessarily indicative of the results that may be expected for the year ending December 31, 2011. For further information, refer to the consolidated financial statements and footnotes thereto included in our annual report on Form 10-K for the year ended December 31, 2010.

Certain prior year amounts have been reclassified to conform to the current year presentation.

NOTE 2 — INCOME TAXES

At March 31, 2011, we were contesting, before the Internal Revenue Service (“IRS”) Appeals Division, certain claimed deficiencies and adjustments proposed by the IRS Examination Division in connection with its audit of HCA Inc.’s 2005 and 2006 federal income tax returns. The disputed items include the timing of recognition of certain patient service revenues, the deductibility of certain debt retirement costs and our method for calculating the tax allowance for doubtful accounts. In addition, eight taxable periods of HCA Inc. and its predecessors ended in 1997 through 2004, for which the primary remaining issue is the computation of the tax allowance for doubtful accounts, were pending before the IRS Examination Division as of March 31, 2011. The IRS Examination Division began an audit of HCA Inc.’s 2007, 2008 and 2009 federal income tax returns in 2010.

Our liability for unrecognized tax benefits was $402 million, including accrued interest of $92 million, as of March 31, 2011 ($413 million and $115 million, respectively, as of December 31, 2010). Unrecognized tax benefits of $197 million ($190 million as of December 31, 2010) would affect the effective rate, if recognized. The liability for unrecognized tax benefits does not reflect deferred tax assets of $54 million ($63 million as of December 31, 2010) related to deductible interest and state income taxes or a refundable deposit of $82 million ($82 million as of December 31, 2010), which is recorded in noncurrent assets. The provision for income taxes reflects $24 million and $15 million ($15 million and $9 million, net of tax) in reductions in interest expense related to taxing authority examinations for the quarters ended March 31, 2011 and 2010, respectively.

Depending on the resolution of the IRS disputes, the completion of examinations by federal, state or international taxing authorities, or the expiration of statutes of limitation for specific taxing jurisdictions, we believe it is reasonably possible our liability for unrecognized tax benefits may significantly increase or decline within the next 12 months. However, we are currently unable to estimate the range of any possible change.

NOTE 3 — EARNINGS PER SHARE

We compute basic earnings per share using the weighted average number of common shares outstanding. We compute diluted earnings per share using the weighted average number of common shares outstanding, plus the dilutive effect of outstanding stock options and restricted share units, computed using the treasury stock method.

7

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 3 — EARNINGS PER SHARE (continued)

The following table sets forth the computation of basic and diluted earnings per share for the quarters ended March 31, 2011 and 2010 (dollars in millions, except per share amounts, and shares in thousands):

	Quarter
	2011		2010
Net income attributable to HCA Holdings, Inc.	$	240	$	388
Weighted average common shares outstanding		444,202		426,350
Effect of dilutive securities		17,767		9,330
Shares used for diluted earnings per share		461,969		435,680
Earnings per share:
Basic earnings per share	$	0.54	$	0.91
Diluted earnings per share	$	0.52	$	0.89

NOTE 4 — INVESTMENTS OF INSURANCE SUBSIDIARY

A summary of our insurance subsidiary’s investments at March 31, 2011 and December 31, 2010 follows (dollars in millions):

	March 31, 2011
			Unrealized
	Amortized		Amounts					Fair
	Cost		Gains		Losses			Value
Debt securities:
States and municipalities	$	296	$	11	$	(2	)	$	305
Auction rate securities		170		—		(1	)		169
Asset-backed securities		24		—		—			24
Money market funds		200		—		—			200
		690		11		(3	)		698
Equity securities		8		1		(1	)		8
	$	698	$	12	$	(4	)		706
Amounts classified as current assets									(116	)
Investment carrying value								$	590

8

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 4 — INVESTMENTS OF INSURANCE SUBSIDIARY (continued)

	December 31, 2010
			Unrealized
	Amortized		Amounts					Fair
	Cost		Gains		Losses			Value
Debt securities:
States and municipalities	$	312	$	12	$	(1	)	$	323
Auction rate securities		251		—		(1	)		250
Asset-backed securities		26		1		(1	)		26
Money market funds		135		—		—			135
		724		13		(3	)		734
Equity securities		8		1		(1	)		8
	$	732	$	14	$	(4	)		742
Amounts classified as current assets									(100	)
Investment carrying value								$	642

At March 31, 2011 and December 31, 2010, the investments of our insurance subsidiary were classified as “available-for-sale.” Changes in temporary unrealized gains and losses are recorded as adjustments to other comprehensive income. At March 31, 2011 and December 31, 2010, $84 million and $92 million, respectively, of our investments were subject to restrictions included in insurance bond collateralization and assumed reinsurance contracts.

Scheduled maturities of investments in debt securities at March 31, 2011 were as follows (dollars in millions):

	Amortized		Fair
	Cost		Value
Due in one year or less	$	225	$	225
Due after one year through five years		147		153
Due after five years through ten years		108		110
Due after ten years		16		17
		496		505
Auction rate securities		170		169
Asset-backed securities		24		24
	$	690	$	698

The average expected maturity of the investments in debt securities at March 31, 2011 was 2.3 years, compared to the average scheduled maturity of 9.4 years. Expected and scheduled maturities may differ because the issuers of certain securities have the right to call, prepay or otherwise redeem such obligations prior to the scheduled maturity date. The average expected maturities for our auction rate and asset-backed securities were derived from valuation models of expected cash flows and involved management’s judgment. At March 31, 2011, the average expected maturities for our auction rate and asset-backed securities were 3.9 years and 5.3 years, respectively, compared to average scheduled maturities of 25.5 years and 25.3 years, respectively.

9

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 5 — LONG-TERM DEBT

A summary of long-term debt at March 31, 2011 and December 31, 2010, including related interest rates at March 31, 2011, follows (dollars in millions):

	March 31,		December 31,
	2011		2010
Senior secured asset-based revolving credit facility	$	—	$	1,875
Senior secured revolving credit facility		—		729
Senior secured term loan facilities (effective interest rate of 6.9%)		7,554		7,530
Senior secured first lien notes (effective interest rate of 8.4%)		4,076		4,075
Other senior secured debt (effective interest rate of 7.1%)		314		322
First lien debt		11,944		14,531
Senior secured cash-pay notes (effective interest rate of 9.7%)		4,502		4,501
Senior secured toggle notes (effective interest rate of 10.0%)		1,578		1,578
Second lien debt		6,080		6,079
Senior unsecured notes (effective interest rate of 7.1%)		7,342		7,615
Total debt (average life of 6.3 years, rates averaging 7.9%)		25,366		28,225
Less amounts due within one year		546		592
	$	24,820	$	27,633

During March 2011, pending permanent application, we used the net proceeds of $2.506 billion from the initial public offering of our common stock to reduce amounts outstanding under our revolving credit facilities.

On November 8, 2010, an amended and restated joinder agreement was entered into with respect to the cash flow credit facility to establish a new replacement revolving credit series, which will mature on November 17, 2015. Under the amended and restated joinder agreement, these replacement revolving credit commitments became effective upon the completion of our initial public offering of our common stock in March 2011.

NOTE 6 — FINANCIAL INSTRUMENTS

Interest Rate Swap Agreements

We have entered into interest rate swap agreements to manage our exposure to fluctuations in interest rates. These swap agreements involve the exchange of fixed and variable rate interest payments between two parties based on common notional principal amounts and maturity dates. Pay-fixed interest rate swaps effectively convert LIBOR indexed variable rate obligations to fixed interest rate obligations. Pay-variable interest rate swaps effectively convert fixed interest rate obligations to LIBOR indexed variable rate obligations. The interest payments under these agreements are settled on a net basis. The net interest payments, based on the notional amounts in these agreements, generally match the timing of the related liabilities, for the interest rate swap agreements which have been designated as cash flow hedges. The notional amounts of the swap agreements represent amounts used to calculate the exchange of cash flows and are not our assets or liabilities. Our credit risk related to these agreements is considered low because the swap agreements are with creditworthy financial institutions.

10

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 6 — FINANCIAL INSTRUMENTS (continued)

Interest Rate Swap Agreements (continued)

The following table sets forth our interest rate swap agreements, which have been designated as cash flow hedges, at March 31, 2011 (dollars in millions):

	Notional				Fair
	Amount		Maturity Date		Value
Pay-fixed interest rate swaps	$	7,100		November 2011	$	(202	)
Pay-fixed interest rate swaps (starting November 2011)		3,000		December 2016		(99	)

Certain of our interest rate swaps are not designated as hedges, and changes in fair value are recognized in results of operations. The following table sets forth our interest rate swap agreements, which were not designated as hedges, at March 31, 2011 (dollars in millions):

	Notional				Fair
	Amount		Maturity Date		Value
Pay-fixed interest rate swap	$	900		November 2011	$	(25	)
Pay-variable interest rate swap		900		November 2011		3

During the next 12 months, we estimate $259 million will be reclassified from other comprehensive income (“OCI”) to interest expense.

Cross Currency Swaps

The Company and certain subsidiaries have incurred obligations and entered into various intercompany transactions where such obligations are denominated in currencies, other than the functional currencies of the parties executing the trade. In order to mitigate the currency exposure risks and better match the cash flows of our obligations and intercompany transactions with cash flows from operations, we entered into various cross currency swaps. Our credit risk related to these agreements is considered low because the swap agreements are with creditworthy financial institutions.

Certain of our cross currency swaps are not designated as hedges, and changes in fair value are recognized in results of operations. The following table sets forth our cross currency swap agreement, which was not designated as a hedge, at March 31, 2011 (amounts in millions):

	Notional				Fair
	Amount		Maturity Date		Value
Euro — United States Dollar currency swap		351 Euro		December 2011	$	67

Derivatives — Results of Operations

The following tables present the effect on our results of operations of our interest rate and cross currency swaps for the quarter ended March 31, 2011 (dollars in millions):

			Location of Loss		Amount of Loss
	Amount of Gain		Reclassified from		Reclassified from
	Recognized in OCI on		Accumulated OCI		Accumulated OCI
Derivatives in Cash Flow Hedging Relationships	Derivatives, Net of Tax		into Operations		into Operations
Interest rate swaps	$	6		Interest expense	$	95

11

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 6 — FINANCIAL INSTRUMENTS (continued)

Derivatives — Results of Operations (continued)

	Location of Gain		Amount of Gain
	Recognized in		Recognized in
	Operations on		Operations on
Derivatives Not Designated as Hedging Instruments	Derivatives		Derivatives
Cross currency swap		Other operating expenses	$	28

Credit-risk-related Contingent Features

We have agreements with each of our derivative counterparties that contain a provision where we could be declared in default on our derivative obligations if repayment of the underlying indebtedness is accelerated by the lender due to our default on the indebtedness. As of March 31, 2011, we have not been required to post any collateral related to these agreements. If we had breached these provisions at March 31, 2011, we would have been required to settle our obligations under the agreements at their aggregate, estimated termination value of $274 million.

NOTE 7 — ASSETS AND LIABILITIES MEASURED AT FAIR VALUE

Accounting Standards Codification (“ASC”) 820, Fair Value Measurements and Disclosures (“ASC 820”) defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements. ASC 820 applies to reported balances that are required or permitted to be measured at fair value under existing accounting pronouncements.

ASC 820 emphasizes fair value is a market-based measurement, not an entity-specific measurement. Therefore, a fair value measurement should be determined based on the assumptions market participants would use in pricing the asset or liability. As a basis for considering market participant assumptions in fair value measurements, ASC 820 establishes a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs classified within Levels 1 and 2 of the hierarchy) and the reporting entity’s own assumptions about market participant assumptions (unobservable inputs classified within Level 3 of the hierarchy).

Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs may include quoted prices for similar assets and liabilities in active markets, as well as inputs observable for the asset or liability (other than quoted prices), such as interest rates, foreign exchange rates, and yield curves observable at commonly quoted intervals. Level 3 inputs are unobservable inputs for the asset or liability, which are typically based on an entity’s own assumptions, as there is little, if any, related market activity. In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input significant to the fair value measurement in its entirety. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the asset or liability.

Cash Traded Investments

Our cash traded investments are generally classified within Level 1 or Level 2 of the fair value hierarchy because they are valued using quoted market prices, broker or dealer quotations, or alternative pricing sources with reasonable levels of price transparency. Certain types of cash traded instruments are classified within Level 3 of the fair value hierarchy because they trade infrequently and therefore have little or no price transparency. Such instruments include auction rate securities (“ARS”) and limited partnership investments. The transaction price is initially used as the best estimate of fair value.

12

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 7 — ASSETS AND LIABILITIES MEASURED AT FAIR VALUE (continued)

Cash Traded Investments (continued)

Our wholly-owned insurance subsidiary had investments in tax-exempt ARS, which are backed by student loans substantially guaranteed by the federal government, of $169 million ($170 million par value) at March 31, 2011. We do not currently intend to attempt to sell the ARS as the liquidity needs of our insurance subsidiary are expected to be met by other investments in its investment portfolio. During 2010 and the first quarter of 2011, certain issuers and their broker/dealers redeemed or repurchased $150 million and $81 million, respectively, of our ARS at par value. The valuation of these securities involved management’s judgment, after consideration of market factors and the absence of market transparency, market liquidity and observable inputs. Our valuation models derived a fair market value compared to tax-equivalent yields of other student loan backed variable rate securities of similar credit worthiness and similar effective maturities.

Derivative Financial Instruments

We have entered into interest rate and cross currency swap agreements to manage our exposure to fluctuations in interest rates and foreign currency risks. The valuation of these instruments is determined using widely accepted valuation techniques, including discounted cash flow analysis on the expected cash flows of each derivative. This analysis reflects the contractual terms of the derivatives, including the period to maturity, and uses observable market-based inputs, including interest rate curves, foreign exchange rates and implied volatilities. To comply with the provisions of ASC 820, we incorporate credit valuation adjustments to reflect both our own nonperformance risk and the respective counterparty’s nonperformance risk in the fair value measurements.

Although we determined the majority of the inputs used to value our derivatives fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with our derivatives utilize Level 3 inputs, such as estimates of current credit spreads to evaluate the likelihood of default by us and our counterparties. We assessed the significance of the impact of the credit valuation adjustments on the overall valuation of our derivative positions and at March 31, 2011 and December 31, 2010, we determined the credit valuation adjustments were not significant to the overall valuation of our derivatives.

13

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 7 — ASSETS AND LIABILITIES MEASURED AT FAIR VALUE (continued)

Fair Value Summary

The following table summarizes our assets and liabilities measured at fair value on a recurring basis as of March 31, 2011 and December 31, 2010, aggregated by the level in the fair value hierarchy within which those measurements fall (dollars in millions):

	March 31, 2011
				Fair Value Measurements Using
				Quoted Prices in
				Active Markets for
				Identical Assets			Significant Other		Significant
				and Liabilities			Observable Inputs		Unobservable Inputs
	Fair Value			(Level 1)			(Level 2)		(Level 3)
Assets:
Investments of insurance subsidiary:
Debt securities:
States and municipalities	$	305		$	—		$	305	$	—
Auction rate securities		169			—			—		169
Asset-backed securities		24			—			24		—
Money market funds		200			200			—		—
		698			200			329		169
Equity securities		8			2			5		1
Investments of insurance subsidiary		706			202			334		170
Less amounts classified as current assets		(116	)		(116	)		—		—
	$	590		$	86		$	334	$	170
Cross currency swap (Other assets)	$	67		$	—		$	67	$	—
Liabilities:
Interest rate swaps (Income taxes and other liabilities)	$	323		$	—		$	323	$	—

14

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 7 — ASSETS AND LIABILITIES MEASURED AT FAIR VALUE (continued)

Fair Value Summary (continued)

	December 31, 2010
				Fair Value Measurements Using
				Quoted Prices in
				Active Markets for
				Identical Assets			Significant Other		Significant
				and Liabilities			Observable Inputs		Unobservable Inputs
	Fair Value			(Level 1)			(Level 2)		(Level 3)
Assets:
Investments of insurance subsidiary:
Debt securities:
States and municipalities	$	323		$	—		$	323	$	—
Auction rate securities		250			—			—		250
Asset-backed securities		26			—			26		—
Money market funds		135			135			—		—
		734			135			349		250
Equity securities		8			2			5		1
Investments of insurance subsidiary		742			137			354		251
Less amounts classified as current assets		(100	)		(100	)		—		—
	$	642		$	37		$	354	$	251
Cross currency swap (Other assets)	$	39		$	—		$	39	$	—
Liabilities:
Interest rate swaps (Income taxes and other liabilities)	$	426		$	—		$	426	$	—

The following table summarizes the activity related to the auction rate and equity securities investments of our insurance subsidiary, which have fair value measurements based on significant unobservable inputs (Level 3), during the quarter ended March 31, 2011 (dollars in millions):

Asset balances at December 31, 2010	$	251
Settlements		(81	)
Asset balances at March 31, 2011	$	170

The estimated fair value of our long-term debt was $26.395 billion and $28.738 billion at March 31, 2011 and December 31, 2010, respectively, compared to carrying amounts aggregating $25.366 billion and $28.225 billion, respectively. The estimates of fair value are generally based upon the quoted market prices or quoted market prices for similar issues of long-term debt with the same maturities.

NOTE 8 — CONTINGENCIES

We operate in a highly regulated and litigious industry. As a result, various lawsuits, claims and legal and regulatory proceedings have been and can be expected to be instituted or asserted against us. The resolution of any such lawsuits, claims or legal and regulatory proceedings could have a material, adverse effect on our results of operations or financial position in a given period.

15

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 8 — CONTINGENCIES (continued)

Health care companies are subject to numerous investigations by various governmental agencies. Under the federal False Claims Act private parties have the right to bring qui tam, or “whistleblower,” suits against companies that submit false claims for payments to, or improperly retain overpayments from, the government. Some states have adopted similar state whistleblower and false claims provisions. Certain of our individual facilities have received government inquiries from federal and state agencies and our facilities may receive such inquiries in future periods. Depending on whether the underlying conduct in these or future inquiries or investigations could be considered systemic, their resolution could have a material, adverse effect on our results of operations or financial position.

We are subject to claims and suits arising in the ordinary course of business, including claims for personal injuries or wrongful restriction of, or interference with, physicians’ staff privileges. In certain of these actions the claimants may seek punitive damages against us which may not be covered by insurance. It is management’s opinion that the ultimate resolution of these pending claims and legal proceedings will not have a material, adverse effect on our results of operations or financial position.

The Civil Division of the Department of Justice (“DOJ”) has contacted the Company in connection with its nationwide review of whether, in certain cases, hospital charges to the federal government relating to implantable cardio-defibrillators (“ICDs”) met the Centers for Medicare & Medicaid Services criteria. In connection with this nationwide review, the DOJ has indicated that it will be reviewing certain ICD billing and medical records at 87 HCA hospitals; the review covers the period from October 2003 to the present. The review could potentially give rise to claims against the Company under the federal False Claims Act or other statutes, regulations or laws. At this time, we cannot predict what effect, if any, this review or any resulting claims could have on the Company.

NOTE 9 — COMPREHENSIVE INCOME AND CAPITAL STRUCTURE

The components of comprehensive income, net of related taxes, for the quarters ended March 31, 2011 and 2010 are only attributable to HCA Holdings, Inc. and are as follows (dollars in millions):

	2011			2010
Net income attributable to HCA Holdings, Inc.	$	240		$	388
Change in fair value of derivative instruments		67			(12	)
Change in fair value of available-for-sale securities		(1	)		1
Foreign currency translation adjustments		14			(21	)
Defined benefit plans		4			3
Comprehensive income	$	324		$	359

The components of accumulated other comprehensive loss, net of related taxes, are as follows (dollars in millions):

	March 31,			December 31,
	2011			2010
Change in fair value of derivative instruments	$	(205	)	$	(272	)
Change in fair value of available-for-sale securities		5			6
Foreign currency translation adjustments		(5	)		(19	)
Defined benefit plans		(139	)		(143	)
Accumulated other comprehensive loss	$	(344	)	$	(428	)

16

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 9 — COMPREHENSIVE INCOME AND CAPITAL STRUCTURE (continued)

The changes in stockholders’ deficit, including changes in stockholders’ deficit attributable to HCA Holdings, Inc. and changes in equity attributable to noncontrolling interests are as follows (dollars in millions):

	Equity (Deficit) Attributable to HCA Holdings, Inc.
					Capital in		Accumulated						Equity
	Common Stock				Excess of		Other						Attributable to
	Shares		Par		Par		Comprehensive			Retained			Noncontrolling
	(000)		Value		Value		Loss			Deficit			Interests			Total
Balances, December 31, 2010		427,459	$	4	$	386	$	(428	)	$	(11,888	)	$	1,132		$	(10,794	)
Net income		—		—		—		—			240			94			334
Other comprehensive income		—		—		—		84			—			—			84
Issuance of common stock		87,719		1		2,505		—			—			—			2,506
Distributions		—		—		—		—			—			(95	)		(95	)
Share-based benefit plans		436		—		9		—			—			—			9
Reclassification of certain equity securities with contingent redemption rights		—		—		141		—			—			—			141
Other		—		—		16		—			—			11			27
Balances, March 31, 2011		515,614	$	5	$	3,057	$	(344	)	$	(11,648	)	$	1,142		$	(7,788	)

During February 2011, our Board of Directors approved an increase in the number of our authorized shares to 1,800,000,000 shares of common stock and a 4.505-to-one split of our issued and outstanding commons shares. During March 2011, we completed the initial public offering of 87,719,300 shares of our common stock at a price of $30.00 per share and realized net proceeds (after costs of the offering) of $2.506 billion.

Prior to the consummation of the initial public offering of our common stock, certain employees could elect to have the Company redeem their common stock and vested options in the event of death or permanent disability, pursuant to the terms of their management stockholder agreements. The consummation of the initial public offering of our common stock effectively terminated the contingent redemption rights and the applicable amounts have been reclassified to stockholders’ equity.

NOTE 10 — SEGMENT AND GEOGRAPHIC INFORMATION

We operate in one line of business, which is operating hospitals and related health care entities. During the quarters ended March 31, 2011 and 2010, 24.8% and 24.5%, respectively, of our revenues related to patients participating in the fee-for-service Medicare program.

Our operations are structured into three geographically organized groups: the National, Southwest and Central Groups. During February 2011, we reorganized our operational groups and have restated the prior period amounts to reflect this reorganization. The National Group includes 64 consolidating hospitals located in Florida, South Carolina, southern Georgia, Alaska, California, Nevada, Utah and Idaho, The Southwest Group includes 39 consolidating hospitals located in Texas, Oklahoma and the Wichita, Kansas market, and the Central Group includes 47 consolidating hospitals located in Louisiana, Indiana, Kentucky, Tennessee, Virginia, New Hampshire, northern Georgia and the Kansas City market. We also operate six consolidating hospitals in England, and these facilities are included in the Corporate and other group.

Adjusted segment EBITDA is defined as income before depreciation and amortization, interest expense, losses on sales of facilities, impairments of long-lived assets, termination of management agreement, income taxes and net income attributable to noncontrolling interests. We use adjusted segment EBITDA as an analytical indicator for purposes of allocating resources to geographic areas and assessing their performance. Adjusted segment EBITDA is commonly used as an analytical indicator within the health care industry, and also serves as a measure of leverage

17

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 10 — SEGMENT AND GEOGRAPHIC INFORMATION (continued)

capacity and debt service ability. Adjusted segment EBITDA should not be considered as a measure of financial performance under generally accepted accounting principles, and the items excluded from adjusted segment EBITDA are significant components in understanding and assessing financial performance. Because adjusted segment EBITDA is not a measurement determined in accordance with generally accepted accounting principles and is thus susceptible to varying calculations, adjusted segment EBITDA, as presented, may not be comparable to other similarly titled measures of other companies. The geographic distributions of our revenues, equity in earnings of affiliates, adjusted segment EBITDA, depreciation and amortization and assets are summarized in the following table (dollars in millions):

	Quarters Ended
	March 31,
	2011			2010
Revenues:
National Group	$	3,455		$	3,203
Southwest Group		2,435			2,338
Central Group		1,879			1,764
Corporate and other		286			239
	$	8,055		$	7,544
Equity in earnings of affiliates:
National Group	$	(1	)	$	(1	)
Southwest Group		(75	)		(66	)
Central Group		—			(1	)
Corporate and other		—			—
	$	(76	)	$	(68	)
Adjusted segment EBITDA:
National Group	$	672		$	662
Southwest Group		595			567
Central Group		333			343
Corporate and other		(10	)		2
	$	1,590		$	1,574
Depreciation and amortization:
National Group	$	125		$	128
Southwest Group		111			107
Central Group		89			88
Corporate and other		33			32
	$	358		$	355
Adjusted segment EBITDA	$	1,590		$	1,574
Depreciation and amortization		358			355
Interest expense		533			516
Losses on sales of facilities		1			—
Impairments of long-lived assets		—			18
Termination of management agreement		181			—
Income before income taxes	$	517		$	685

18

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 10 — SEGMENT AND GEOGRAPHIC INFORMATION (continued)

	March 31,		December 31,
	2011		2010
Assets:
National Group	$	7,396	$	7,345
Southwest Group		6,791		6,747
Central Group		5,283		5,271
Corporate and other		4,339		4,489
	$	23,809	$	23,852

NOTE 11 — ACQUISITIONS, DISPOSITIONS AND IMPAIRMENTS OF LONG-LIVED ASSETS

During the quarters ended March 31, 2011 and 2010, we paid $22 million and $21 million, respectively, to acquire nonhospital health care entities.

During the quarter ended March 31, 2011, we received proceeds of $55 million and recognized a net pretax loss of $1 million related to the sales of a hospital facility and our investment in a hospital joint venture. During the quarter ended March 31, 2010, we received proceeds of $24 million related to sales of real estate investments and the proceeds were equal to the carrying amounts.

During the quarter ended March 31, 2010, we recorded impairments of long-lived assets of $18 million to adjust the values of real estate and other investments in our National, Southwest and Corporate and Other Groups to estimated fair value. There were no impairments of long-lived assets for the quarter ended March 31, 2011.

NOTE 12 — SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION

On November 22, 2010, HCA Inc. reorganized by creating a new holding company structure. HCA Holdings, Inc. became the new parent company, and HCA Inc. is now HCA Holdings, Inc.’s wholly-owned direct subsidiary. On November 23, 2010, HCA Holdings, Inc. issued $1.525 billion aggregate principal amount of 73/4% senior unsecured notes due 2021. These notes are senior unsecured obligations and are not guaranteed by any of our subsidiaries.

Our senior secured credit facilities and senior secured notes are fully and unconditionally guaranteed by substantially all existing and future, direct and indirect, wholly-owned material domestic subsidiaries that are “Unrestricted Subsidiaries” under our Indenture dated December 16, 1993 (except for certain special purpose subsidiaries that only guarantee and pledge their assets under our senior secured asset-based revolving credit facility).

Our summarized condensed consolidating balance sheets at March 31, 2011 and December 31, 2010 and condensed consolidating statements of income and cash flows for the quarters ended March 31, 2011 and 2010, segregating HCA Holdings, Inc. issuer, HCA Inc. issuer, the subsidiary guarantors, the subsidiary non-guarantors and eliminations, follow:

19

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 12 — SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION (continued)

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING INCOME STATEMENT

FOR THE QUARTER ENDED MARCH 31, 2011

(Dollars in millions)

	HCA									Subsidiary
	Holdings, Inc.			HCA Inc.			Subsidiary			Non-						Condensed
	Issuer			Issuer			Guarantors			Guarantors			Eliminations			Consolidated
Revenues	$	—		$	—		$	4,578		$	3,477		$	—		$	8,055
Salaries and benefits		—			—			1,896			1,399			—			3,295
Supplies		—			—			711			564			—			1,275
Other operating expenses		—			2			681			639			—			1,322
Provision for doubtful accounts		—			—			417			232			—			649
Equity in earnings of affiliates		(258	)		—			(30	)		(46	)		258			(76	)
Depreciation and amortization		—			—			195			163			—			358
Interest expense		30			691			(163	)		(25	)		—			533
Losses (gains) on sales of facilities		—			—			16			(15	)		—			1
Termination of management agreement		—			181			—			—			—			181
Management fees		—			—			(124	)		124			—			—
		(228	)		874			3,599			3,035			258			7,538
Income (loss) before income taxes		228			(874	)		979			442			(258	)		517
Provision for income taxes		(12	)		(375	)		415			155			—			183
Net income (loss)		240			(499	)		564			287			(258	)		334
Net income attributable to noncontrolling interests		—			—			13			81			—			94
Net income (loss) attributable to HCA Holdings, Inc.	$	240		$	(499	)	$	551		$	206		$	(258	)	$	240

20

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 12 — SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION (continued)

HCA HOLDINGS, INC.
CONDENSED CONSOLIDATING INCOME STATEMENT
FOR THE QUARTER ENDED MARCH 31, 2010
(Dollars in millions)

							Subsidiary
	HCA Inc.			Subsidiary			Non-						Condensed
	Issuer			Guarantors			Guarantors			Eliminations			Consolidated
Revenues	$	—		$	4,374		$	3,170		$	—		$	7,544
Salaries and benefits		—			1,826			1,246			—			3,072
Supplies		—			690			510			—			1,200
Other operating expenses		2			638			562			—			1,202
Provision for doubtful accounts		—			358			206			—			564
Equity in earnings of affiliates		(811	)		(27	)		(41	)		811			(68	)
Depreciation and amortization		—			195			160			—			355
Interest expense		648			(115	)		(17	)		—			516
Impairments of long-lived assets		—			15			3			—			18
Management fees		—			(118	)		118			—			—
		(161	)		3,462			2,747			811			6,859
Income before income taxes		161			912			423			(811	)		685
Provision for income taxes		(227	)		313			123			—			209
Net income		388			599			300			(811	)		476
Net income attributable to noncontrolling interests		—			15			73			—			88
Net income attributable to HCA Holdings, Inc.	$	388		$	584		$	227		$	(811	)	$	388

21

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 12 — SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION (continued)

HCA HOLDINGS, INC.
CONDENSED CONSOLIDATING BALANCE SHEET
MARCH 31, 2011
(Dollars in millions)

	HCA									Subsidiary
	Holdings, Inc.			HCA Inc.			Subsidiary			Non-					Condensed
	Issuer			Issuer			Guarantors			Guarantors		Eliminations			Consolidated
ASSETS
Current assets:
Cash and cash equivalents	$	—		$	—		$	270		$	283	$	—		$	553
Accounts receivable, net		—			—			2,288			1,772		—			4,060
Inventories		—			—			539			342		—			881
Deferred income taxes		916			—			—			—		—			916
Other		—			—			170			406		—			576
		916			—			3,267			2,803		—			6,986
Property and equipment, net		—			—			6,786			4,561		—			11,347
Investments of insurance subsidiary		—			—			—			590		—			590
Investments in and advances to affiliates		—			—			223			629		—			852
Goodwill		—			—			1,631			1,074		—			2,705
Deferred loan costs		23			331			—			—		—			354
Investments in and advances to subsidiaries		14,540			—			—			—		(14,540	)		—
Other		678			90			24			183		—			975
	$	16,157		$	421		$	11,931		$	9,840	$	(14,540	)	$	23,809
LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY
Current liabilities:
Accounts payable	$	4		$	—		$	780		$	564	$	—		$	1,348
Accrued salaries		—			—			596			379		—			975
Other accrued expenses		108			380			277			633		—			1,398
Long-term debt due within one year		—			508			13			25		—			546
		112			888			1,666			1,601		—			4,267
Long-term debt		1,525			22,946			100			249		—			24,820
Intercompany balances		23,053			(12,792	)		(13,180	)		2,919		—			—
Professional liability risks		—			—			—			1,003		—			1,003
Income taxes and other liabilities		397			391			522			197		—			1,507
		25,087			11,433			(10,892	)		5,969		—			31,597
Stockholders’ (deficit) equity attributable to HCA Holdings, Inc.		(8,930	)		(11,012	)		22,718			2,834		(14,540	)		(8,930	)
Noncontrolling interests		—			—			105			1,037		—			1,142
		(8,930	)		(11,012	)		22,823			3,871		(14,540	)		(7,788	)
	$	16,157		$	421		$	11,931		$	9,840	$	(14,540	)	$	23,809

22

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 12 — SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION (continued)

HCA HOLDINGS, INC.
CONDENSED CONSOLIDATING BALANCE SHEET
DECEMBER 31, 2010
(Dollars in millions)

	HCA									Subsidiary
	Holdings, Inc.			HCA Inc.			Subsidiary			Non-					Condensed
	Issuer			Issuer			Guarantors			Guarantors		Eliminations			Consolidated
ASSETS
Current assets:
Cash and cash equivalents	$	6		$	—		$	156		$	249	$	—		$	411
Accounts receivable, net		—			—			2,214			1,618		—			3,832
Inventories		—			—			547			350		—			897
Deferred income taxes		931			—			—			—		—			931
Other		202			—			223			423		—			848
		1,139			—			3,140			2,640		—			6,919
Property and equipment, net		—			—			6,817			4,535		—			11,352
Investments of insurance subsidiary		—			—			—			642		—			642
Investments in and advances to affiliates		—			—			248			621		—			869
Goodwill		—			—			1,635			1,058		—			2,693
Deferred loan costs		23			351			—			—		—			374
Investments in and advances to subsidiaries		14,282			—			—			—		(14,282	)		—
Other		776			39			21			167		—			1,003
	$	16,220		$	390		$	11,861		$	9,663	$	(14,282	)	$	23,852
LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY
Current liabilities:
Accounts payable	$	—		$	—		$	919		$	618	$	—		$	1,537
Accrued salaries		—			—			556			339		—			895
Other accrued expenses		12			296			328			609		—			1,245
Long-term debt due within one year		—			554			12			26		—			592
		12			850			1,815			1,592		—			4,269
Long-term debt		1,525			25,758			95			255		—			27,633
Intercompany balances		25,985			(16,130	)		(12,833	)		2,978		—			—
Professional liability risks		—			—			—			995		—			995
Income taxes and other liabilities		483			425			505			195		—			1,608
		28,005			10,903			(10,418	)		6,015		—			34,505
Equity securities with contingent redemption rights		141			—			—			—		—			141
Stockholders’ (deficit) equity attributable to HCA Holdings, Inc.		(11,926	)		(10,513	)		22,167			2,628		(14,282	)		(11,926	)
Noncontrolling interests		—			—			112			1,020		—			1,132
		(11,926	)		(10,513	)		22,279			3,648		(14,282	)		(10,794	)
	$	16,220		$	390		$	11,861		$	9,663	$	(14,282	)	$	23,852

23

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 12 — SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION (continued)

HCA HOLDINGS, INC.
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
FOR THE QUARTER ENDED MARCH 31, 2011
(Dollars in millions)

	HCA									Subsidiary
	Holdings, Inc.			HCA Inc.			Subsidiary			Non-						Condensed
	Issuer			Issuer			Guarantors			Guarantors			Eliminations			Consolidated
Cash flows from operating activities:
Net income	$	240		$	(499	)	$	564		$	287		$	(258	)	$	334
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Changes in operating assets and liabilities		34			85			(559	)		(334	)		—			(774	)
Provision for doubtful accounts		—			—			417			232			—			649
Depreciation and amortization		—			—			195			163			—			358
Income taxes		321			—			—			—			—			321
Losses (gains) on sales of facilities		—			—			15			(14	)		—			1
Amortization of deferred loan costs		—			20			—			—			—			20
Share-based compensation		8			—			—			—			—			8
Equity in earnings of affiliates		(258	)		—			—			—			258			—
Other		—			1			—			—			—			1
Net cash provided by (used in) operating activities		345			(393	)		632			334			—			918
Cash flows from investing activities:
Purchase of property and equipment		—			—			(168	)		(161	)		—			(329	)
Acquisition of hospitals and health care entities		—			—			—			(22	)		—			(22	)
Disposition of hospitals and health care entities		—			—			1			54			—			55
Change in investments		—			—			28			(8	)		—			20
Other		—			—			(4	)		7			—			3
Net cash used in investing activities		—			—			(143	)		(130	)		—			(273	)
Cash flows from financing activities:
Net change in revolving bank credit facilities		—			(2,604	)		—			—			—			(2,604	)
Repayment of long-term debt		—			(284	)		—			(12	)		—			(296	)
Distributions to noncontrolling interests		—			—			(20	)		(75	)		—			(95	)
Distributions to stockholders		(30	)		—			—			—			—			(30	)
Changes in intercompany balances with affiliates, net		(2,843	)		3,281			(355	)		(83	)		—			—
Issuances of common stock		2,506			—			—			—			—			2,506
Income tax benefits		22			—			—			—			—			22
Other		(6	)		—			—			—			—			(6	)
Net cash provided by (used in) financing activities		(351	)		393			(375	)		(170	)		—			(503	)
Change in cash and cash equivalents		(6	)		—			114			34			—			142
Cash and cash equivalents at beginning of period		6			—			156			249			—			411
Cash and cash equivalents at end of period	$	—		$	—		$	270		$	283		$	—		$	553

24

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 12 — SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION (continued)

HCA HOLDINGS, INC.
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
FOR THE QUARTER ENDED MARCH 31, 2010
(Dollars in millions)

							Subsidiary
	HCA Inc.			Subsidiary			Non-						Condensed
	Issuer			Guarantors			Guarantors			Eliminations			Consolidated
Cash flows from operating activities:
Net income	$	388		$	599		$	300		$	(811	)	$	476
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Changes in operating assets and liabilities		116			(670	)		(284	)		—			(838	)
Provision for doubtful accounts		—			358			206			—			564
Depreciation and amortization		—			195			160			—			355
Income taxes		238			—			—			—			238
Impairments of long-lived assets		—			15			3			—			18
Amortization of deferred loan costs		20			—			—			—			20
Share-based compensation		8			—			—			—			8
Equity in earnings of affiliates		(811	)		—			—			811			—
Other		18			—			—			—			18
Net cash provided by (used in) operating activities		(23	)		497			385			—			859
Cash flows from investing activities:
Purchase of property and equipment		—			(53	)		(161	)		—			(214	)
Acquisition of hospitals and health care entities		—			(21	)		—			—			(21	)
Disposition of hospitals and health care entities		—			23			1			—			24
Change in investments		—			7			22			—			29
Other		—			(3	)		4			—			1
Net cash used in investing activities		—			(47	)		(134	)		—			(181	)
Cash flows from financing activities:
Issuance of long-term debt		1,387			—			—			—			1,387
Net change in revolving credit facilities		1,339			—			—			—			1,339
Repayment of long-term debt		(1,496	)		(11	)		(3	)		—			(1,510	)
Distributions to noncontrolling interests		—			(33	)		(50	)		—			(83	)
Distributions to stockholders		(1,751	)		—			—			—			(1,751	)
Changes in intercompany balances with affiliates, net		532			(421	)		(111	)		—			—
Payment of debt issuance costs		(25	)		—			—			—			(25	)
Income tax benefits		42			—			—			—			42
Other		(5	)		—			4			—			(1	)
Net cash provided by (used in) financing activities		23			(465	)		(160	)		—			(602	)
Change in cash and cash equivalents		—			(15	)		91			—			76
Cash and cash equivalents at beginning of period		—			95			217			—			312
Cash and cash equivalents at end of period	$	—		$	80		$	308		$	—		$	388

25

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward-Looking Statements

This quarterly report on Form 10-Q includes certain disclosures which contain “forward-looking statements.” Forward-looking statements include all statements that do not relate solely to historical or current facts, and can be identified by the use of words like “may,” “believe,” “will,” “expect,” “project,” “estimate,” “anticipate,” “plan,” “initiative” or “continue.” These forward-looking statements are based on our current plans and expectations and are subject to a number of known and unknown uncertainties and risks, many of which are beyond our control, which could significantly affect current plans and expectations and our future financial position and results of operations. These factors include, but are not limited to, (1) the impact of our substantial indebtedness and the ability to refinance such indebtedness on acceptable terms, (2) the effects related to the enactment and implementation of the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act (collectively, the “Health Reform Law”), the possible enactment of additional federal or state health care reforms and possible changes to the Health Reform Law and other federal, state or local laws or regulations affecting the health care industry, (3) increases in the amount and risk of collectibility of uninsured accounts and deductibles and copayment amounts for insured accounts, (4) the ability to achieve operating and financial targets, and attain expected levels of patient volumes and control the costs of providing services, (5) possible changes in the Medicare, Medicaid and other state programs, including Medicaid supplemental payments pursuant to upper payment limit (“UPL”) programs, that may impact reimbursements to health care providers and insurers, (6) the highly competitive nature of the health care business, (7) changes in revenue mix, including potential declines in the population covered under managed care agreements and the ability to enter into and renew managed care provider agreements on acceptable terms, (8) the efforts of insurers, health care providers and others to contain health care costs, (9) the outcome of our continuing efforts to monitor, maintain and comply with appropriate laws, regulations, policies and procedures, (10) increases in wages and the ability to attract and retain qualified management and personnel, including affiliated physicians, nurses and medical and technical support personnel, (11) the availability and terms of capital to fund the expansion of our business and improvements to our existing facilities, (12) changes in accounting practices, (13) changes in general economic conditions nationally and regionally in our markets, (14) future divestitures which may result in charges and possible impairments of long-lived assets, (15) changes in business strategy or development plans, (16) delays in receiving payments for services provided, (17) the outcome of pending and any future tax audits, appeals and litigation associated with our tax positions, (18) potential adverse impact of known and unknown government investigations, litigation and other claims that may be made against us, (19) our ability to demonstrate meaningful use of certified electronic health record technology and recognize revenues for the related Medicare or Medicaid incentive payments, and (20) other risk factors described in our annual report on Form 10-K for the year ended December 31, 2010 and our other filings with the Securities and Exchange Commission. As a consequence, current plans, anticipated actions and future financial position and results of operations may differ from those expressed in any forward-looking statements made by or on behalf of HCA. You are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in this report, which forward-looking statements reflect management’s views only as of the date of this report. We undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise.

Health Care Reform

As enacted, the Health Reform Law will change how health care services are covered, delivered and reimbursed through expanded coverage of uninsured individuals, reduced growth in Medicare program spending, reductions in Medicare and Medicaid Disproportionate Share Hospital payments, and the establishment of programs in which reimbursement is tied to quality and integration. In addition, the Health Reform Law reforms certain aspects of health insurance, expands existing efforts to tie Medicare and Medicaid payments to performance and quality, and contains provisions intended to strengthen fraud and abuse enforcement. For a more detailed discussion of the Health Reform Law and its potential impact on the Company, see Part I, Item 1, “Business — Health Care Reform” in our Form 10-K for the year ended December 31, 2010.

26

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)

First Quarter 2011 Operations Summary

Net income attributable to HCA Holdings, Inc. totaled $240 million, or $0.52 per diluted share, for the quarter ended March 31, 2011, compared to $388 million, or $0.89 per diluted share, for the quarter ended March 31, 2010. Revenues increased to $8.055 billion in the first quarter of 2011 from $7.544 billion in the first quarter of 2010. First quarter 2011 results include losses on sales of facilities of $1 million, or $0.01 per diluted share, and a charge of $181 million, or $0.32 per diluted share, related to the termination of the management agreement between HCA and the Investors upon completion of our initial public offering. First quarter 2010 results include impairments of long-lived assets of $18 million, or $0.03 per diluted share. (All “per diluted share” disclosures are based upon amounts net of the applicable income taxes.) Shares used for diluted earnings per share were 462.0 million shares for the quarter ended March 31, 2011 and 435.7 million shares for the quarter ended March 31, 2010. We completed the initial public offering of 87.7 million shares of our common stock on March 15, 2011, and those shares are reflected in the weighted average shares used for earnings per share calculations for the portion of the quarter subsequent to the consummation of the offering.

Revenues increased 6.8% on a consolidated basis and increased 6.0% on a same facility basis for the quarter ended March 31, 2011, compared to the quarter ended March 31, 2010. The increase in consolidated revenues can be attributed primarily to the combined impact of a 2.9% increase in revenue per equivalent admission and a 3.7% increase in equivalent admissions. The same facility revenues increase resulted primarily from the combined impact of a 2.6% increase in same facility revenue per equivalent admission and a 3.3% increase in same facility equivalent admissions.

During the quarter ended March 31, 2011, consolidated admissions and same facility admissions increased 2.0% and 1.6%, respectively, compared to the quarter ended March 31, 2010. Inpatient surgeries declined 2.2% on a consolidated basis and 2.3% on a same facility basis during the quarter ended March 31, 2011, compared to the quarter ended March 31, 2010. Outpatient surgeries increased 1.2% on a consolidated basis and 1.0% on a same facility basis during the quarter ended March 31, 2011, compared to the quarter ended March 31, 2010. Emergency department visits increased 11.7% on a consolidated basis and 11.3% on a same facility basis during the quarter ended March 31, 2011, compared to the quarter ended March 31, 2010.

For the quarter ended March 31, 2011, the provision for doubtful accounts increased $85 million to 8.1% of revenues from 7.5% of revenues for the quarter ended March 31, 2010. The self-pay revenue deductions for charity care and uninsured discounts increased $90 million and $238 million, respectively, during the first quarter of 2011, compared to the first quarter of 2010. The sum of the provision for doubtful accounts, uninsured discounts and charity care, as a percentage of the sum of revenues, uninsured discounts and charity care, was 25.7% for the first quarter of 2011, compared to 23.5% for the first quarter of 2010. Same facility uninsured admissions increased 4.7% and same facility uninsured emergency room visits increased 10.6% for the quarter ended March 31, 2011, compared to the quarter ended March 31, 2010.

Interest expense increased $17 million to $533 million for the quarter ended March 31, 2011 from $516 million for the quarter ended March 31, 2010. The additional interest expense was due to an increase in the average debt balance.

Cash flows from operating activities increased $59 million from $859 million for the first quarter of 2010 to $918 million for the first quarter of 2011. The increase related primarily to the combined impact of positive cash flows from changes in working capital items and income tax refunds more than offsetting the decline in net income, which was primarily due to the termination of the management agreement charge.

Results of Operations

Revenue/Volume Trends

Our revenues depend upon inpatient occupancy levels, the ancillary services and therapy programs ordered by physicians and provided to patients, the volume of outpatient procedures and the charge and negotiated payment rates for such services. Gross charges typically do not reflect what our facilities are actually paid. Our facilities have

27

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)

Results of Operations (continued)

Revenue/Volume Trends (continued)

entered into agreements with third-party payers, including government programs and managed care health plans, under which the facilities are paid based upon the cost of providing services, predetermined rates per diagnosis, fixed per diem rates or discounts from gross charges. We do not pursue collection of amounts related to patients who meet our guidelines to qualify for charity care; therefore, they are not reported in revenues. We provide discounts to uninsured patients who do not qualify for Medicaid or charity care that are similar to the discounts provided to many local managed care plans.

Revenues increased 6.8% from $7.544 billion in the first quarter of 2010 to $8.055 billion in the first quarter of 2011. Revenues are recorded during the period the health care services are provided, based upon the estimated amounts due from the patients and third-party payers. Third-party payers include federal and state agencies (under the Medicare and Medicaid programs), managed care health plans, commercial insurance companies and employers. Estimates of contractual allowances under managed care health plans are based upon the payment terms specified in the related contractual agreements. Revenues related to uninsured patients and copayment and deductible amounts for patients who have health care coverage may have discounts applied (uninsured discounts and contractual discounts). We also record a provision for doubtful accounts (based primarily on historical collection experience) related to uninsured accounts to record the net self pay accounts receivable at the estimated amounts we expect to collect. Our revenues from our third party payers and the uninsured for quarters ended March 31, 2011 and 2010 are summarized in the following table (dollars in millions):

	2011		Ratio			2010		Ratio
Medicare	$	2,000		24.8	%	$	1,851		24.5	%
Managed Medicare		612		7.6			550		7.3
Medicaid		508		6.3			478		6.3
Managed Medicaid		319		4.0			297		3.9
Managed care and other insurers		3,993		49.6			3,832		50.9
International (managed care and other insurers)		233		2.9			189		2.5
		7,665		95.2			7,197		95.4
Uninsured		390		4.8			347		4.6
Revenues	$	8,055		100.0	%	$	7,544		100.0	%

Consolidated and same facility revenue per equivalent admission increased 2.9% and 2.6%, respectively, in the first quarter of 2011, compared to the first quarter of 2010. Consolidated and same facility equivalent admissions increased 3.7% and 3.3%, respectively, in the first quarter of 2011, compared to the first quarter of 2010. Consolidated and same facility admissions increased 2.0% and 1.6%, respectively, in the first quarter of 2011, compared to the first quarter of 2010. Consolidated and same facility outpatient surgeries increased 1.2% and 1.0%, respectively, in the first quarter of 2011, compared to the first quarter of 2010. Consolidated and same facility inpatient surgeries declined 2.2% and 2.3%, respectively, in the first quarter of 2011, compared to the first quarter of 2010. Consolidated and same facility emergency department visits increased 11.7% and 11.3%, respectively, in the first quarter of 2011, compared to the first quarter of 2010.

28

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)

Results of Operations (continued)

Revenue/Volume Trends (continued)

To quantify the total impact of and trends related to uninsured accounts, we believe it is beneficial to view the uninsured revenue deductions and provision for doubtful accounts in combination, rather than each separately. A summary of these amounts for the quarters ended March 31, 2011 and 2010 follows (dollars in millions):

	2011		Ratio			2010		Ratio
Provision for doubtful accounts	$	649		25	%	$	564		26	%
Uninsured discounts		1,273		50			1,035		48
Charity care		635		25			545		26
Totals	$	2,557		100	%	$	2,144		100	%

Same facility uninsured admissions increased by 1,198 admissions, or 4.7%, in the first quarter of 2011, compared to the first quarter of 2010. Same facility uninsured admissions in 2010, compared to 2009, increased 8.9% in the fourth quarter of 2010, increased 3.9% in the third quarter of 2010, increased 2.1% in the second quarter of 2010 and increased 6.8% in the first quarter of 2010.

The approximate percentages of our admissions related to Medicare, managed Medicare, Medicaid, managed Medicaid, managed care and other insurers and the uninsured for the quarters ended March 31, 2011 and 2010 are set forth in the following table.

	2011			2010
Medicare		35	%		35	%
Managed Medicare		11			11
Medicaid		9			9
Managed Medicaid		7			7
Managed care and other insurers		31			32
Uninsured		7			6
		100	%		100	%

The approximate percentages of our inpatient revenues related to Medicare, managed Medicare, Medicaid, managed Medicaid, managed care and other insurers and the uninsured for the quarters ended March 31, 2011 and 2010 are set forth in the following table.

	2011			2010
Medicare		33	%		32	%
Managed Medicare		9			9
Medicaid		9			9
Managed Medicaid		4			4
Managed care and other insurers		43			44
Uninsured		2			2
		100	%		100	%

At March 31, 2011, we had 74 hospitals in the states of Texas and Florida. During the first quarter of 2011, 58% of our admissions and 52% of our revenues were generated by these hospitals. Uninsured admissions in Texas and Florida represented 64% of our uninsured admissions during the first quarter of 2011.

29

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)

Results of Operations (continued)

Revenue/Volume Trends (continued)

We receive a significant portion of our revenues from government health programs, principally Medicare and Medicaid, which are highly regulated and subject to frequent and substantial changes. We provide indigent care services in several communities in the state of Texas, in affiliation with other hospitals. The state of Texas has been involved in efforts to increase the indigent care provided by private hospitals. Additional indigent care provided by private hospitals allows public hospital districts or counties in Texas to have funds available that were previously devoted to indigent care. The public hospital districts or counties are under no contractual or legal obligation to provide such indigent care. The public hospital districts or counties have elected to transfer some portion of these available funds to the state’s Medicaid program. Such action is at the sole discretion of the public hospital districts or counties. It is anticipated that these contributions to the state will be matched with federal Medicaid funds. The state then may make supplemental payments to hospitals in the state for Medicaid services rendered. Hospitals receiving Medicaid supplemental payments may include those that are providing additional indigent care services. Such payments must be within the federal UPL established by federal regulation. Our Texas Medicaid revenues included $167 million and $169 million during the first quarters of 2011 and 2010, respectively, of Medicaid supplemental payments pursuant to UPL programs.

The American Recovery and Reinvestment Act of 2009 provides for Medicare and Medicaid incentive payments beginning in 2011 for eligible hospitals and professionals that adopt and meaningfully use certified electronic health record (“EHR”) technology. We will recognize revenues related to the Medicare or Medicaid incentive payments as we are able to complete attestations as to our eligible hospitals adopting, implementing or demonstrating meaningful use of certified EHR technology. We estimate that during 2011 the amount of Medicare and Medicaid incentive payments realizable (and revenues recognized) will be in the range of $290 million to $340 million. We estimate that approximately 80% of our total expected incentive payments for 2011 relate to Medicare incentives, and we expect to recognize the applicable revenues primarily during the fourth quarter of 2011. We estimate that we will begin recognizing revenues related to Medicaid incentive payments from certain states during the second quarter of 2011 and for additional state programs during the third and fourth quarters of 2011. Actual incentive payments could vary from these estimates due to certain factors such as availability of federal funding for both Medicare and Medicaid incentive payments, timing of the approval of state Medicaid incentive payment plans by Centers for Medicare & Medicaid Services (“CMS”) and our ability to implement and demonstrate meaningful use of certified EHR technology. We have incurred and will continue to incur both capital costs and operating expenses in order to implement our certified EHR technology and meet meaningful use requirements. These expenses are ongoing and are projected to continue over all stages of implementation of meaningful use. The timing of recognizing the expenses will not correlate with the receipt of the incentive payments and the recognition of revenues. We estimate that operating expenses to implement our certified EHR technology and meet meaningful use will be in the range of $115 million to $140 million for 2011. Actual operating expenses could vary from these estimates. There can be no assurance that we will be able to demonstrate meaningful use of certified EHR technology, and the failure to do so could have a material, adverse effect on our results of operations.

30

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)

Results of Operations (continued)

Revenue/Volume Trends (continued)

Operating Results Summary

The following are comparative summaries of results from operations for the quarters ended March 31, 2011 and 2010 (dollars in millions):

	2011						2010
	Amount			Ratio			Amount			Ratio
Revenues	$	8,055			100.0		$	7,544			100.0
Salaries and benefits		3,295			40.9			3,072			40.7
Supplies		1,275			15.8			1,200			15.9
Other operating expenses		1,322			16.4			1,202			15.9
Provision for doubtful accounts		649			8.1			564			7.5
Equity in earnings of affiliates		(76	)		(0.9	)		(68	)		(0.9	)
Depreciation and amortization		358			4.5			355			4.8
Interest expense		533			6.6			516			6.8
Losses on sales of facilities		1			—			—			—
Impairments of long-lived assets		—			—			18			0.2
Termination of management agreement		181			2.2			—			—
		7,538			93.6			6,859			90.9
Income before income taxes		517			6.4			685			9.1
Provision for income taxes		183			2.3			209			2.8
Net income		334			4.1			476			6.3
Net income attributable to noncontrolling interests		94			1.1			88			1.1
Net income attributable to HCA Holdings, Inc.	$	240			3.0		$	388			5.2
% changes from prior year:
Revenues		6.8	%					1.5	%
Income before income taxes		(24.5	)					10.6
Net income attributable to HCA Holdings, Inc.		(38.2	)					8.1
Admissions(a)		2.0						0.7
Equivalent admissions(b)		3.7						0.9
Revenue per equivalent admission		2.9						0.6
Same facility % changes from prior year(c):
Revenues		6.0						1.5
Admissions(a)		1.6						0.9
Equivalent admissions(b)		3.3						1.1
Revenue per equivalent admission		2.6						0.4

(a)	Represents the total number of patients admitted to our hospitals and is used by management and certain investors as a general measure of inpatient volume.
(b)	Equivalent admissions are used by management and certain investors as a general measure of combined inpatient and outpatient volume. Equivalent admissions are computed by multiplying admissions (inpatient volume) by the sum of gross inpatient revenues and gross outpatient revenues and then dividing the resulting amount by gross inpatient revenues. The equivalent admissions computation “equates” outpatient revenues to the volume measure (admissions) used to measure inpatient volume, resulting in a general measure of combined inpatient and outpatient volume.
(c)	Same facility information excludes the operations of hospitals and their related facilities which were either acquired or divested during the current and prior period.

31

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)

Results of Operations (continued)

Operating Results Summary (continued)

Supplemental Non-GAAP Disclosures
Operating Measures on a Cash Revenues Basis
(Dollars in millions)

The results from operations presented on a cash revenues basis for the quarters ended March 31, 2011 and 2010 follow:

	2011							2010
				Non-GAAP % of		GAAP % of				Non-GAAP % of		GAAP % of
				Cash Revenues		Revenues				Cash Revenues		Revenues
	Amount			Ratios(b)		Ratios(b)		Amount		Ratios(b)		Ratios(b)
Revenues	$	8,055					100.0	$	7,544				100.0
Provision for doubtful accounts		649							564
Cash revenues(a)		7,406			100.0				6,980		100.0
Salaries and benefits		3,295			44.5		40.9		3,072		44.0		40.7
Supplies		1,275			17.2		15.8		1,200		17.2		15.9
Other operating expenses		1,322			17.8		16.4		1,202		17.3		15.9
% changes from prior year:
Revenues		6.8	%
Cash revenues		6.1
Revenue per equivalent admission		2.9
Cash revenue per equivalent admission		2.3

(a) Cash revenues is defined as reported revenues less the provision for doubtful accounts. We use cash revenues as an analytical indicator for purposes of assessing the effect of uninsured patient volumes, adjusted for the effect of both the revenue deductions related to uninsured accounts (charity care and uninsured discounts) and the provision for doubtful accounts (which relates primarily to uninsured accounts), on our revenues and certain operating expenses, as a percentage of cash revenues. During the first quarter of 2011, uninsured discounts increased $238 million, charity care increased $90 million and the provision for doubtful accounts increased $85 million, compared to the same period for 2010. Cash revenues is commonly used as an analytical indicator within the health care industry. Cash revenues should not be considered as a measure of financial performance under generally accepted accounting principles (“GAAP”). Because cash revenues is not a measurement determined in accordance with GAAP and is thus susceptible to varying calculations, cash revenues, as presented, may not be comparable to other similarly titled measures of other health care companies.

(b) Salaries and benefits, supplies and other operating expenses, as a percentage of cash revenues (a non-GAAP financial measure), present the impact on these ratios due to the adjustment of deducting the provision for doubtful accounts from reported revenues and results in these ratios being non-GAAP financial measures. We believe these non-GAAP financial measures are useful to investors to provide disclosures of our results of operations on the same basis as that used by management. Management uses this information to compare certain operating expense categories as a percentage of cash revenues. Management finds this information useful to evaluate certain expense category trends without the influence of whether adjustments related to revenues for uninsured accounts are recorded as revenue adjustments (charity care and uninsured discounts) or operating expenses (provision for doubtful accounts), and thus the expense category trends are generally analyzed as a percentage of cash revenues. These non-GAAP financial measures should not be considered alternatives to GAAP financial measures. We believe this supplemental information provides management and the users of our financial statements with useful information for period-to-period comparisons. Investors are encouraged to use GAAP measures when evaluating our overall financial performance.

32

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)

Results of Operations (continued)

Quarters Ended March 31, 2011 and 2010

Net income attributable to HCA Holdings, Inc. totaled $240 million, or $0.52 per diluted share, for the first quarter of 2011 compared to $388 million, or $0.89 per diluted share, for the first quarter of 2010. The $148 million decline in net income attributable to HCA Holdings, Inc. for the first quarter of 2011, compared to the first quarter of 2010, was primarily due to the first quarter 2011 termination of management agreement charge of $181 million (pretax), or $0.32 per diluted share. Revenues increased 6.8% due to the combined impact of revenue per equivalent admission growth of 2.9% and an increase of 3.7% in equivalent admissions for the first quarter of 2011 compared to the first quarter of 2010. Cash revenues (reported revenues less the provision for doubtful accounts) increased 6.1% for the first quarter of 2011 compared to the first quarter of 2010.

For the first quarter of 2011, consolidated and same facility admissions increased 2.0% and 1.6%, respectively, compared to the first quarter of 2010. Consolidated and same facility outpatient surgical volumes increased 1.2% and 1.0%, respectively, during the first quarter of 2011, compared to the first quarter of 2010. Consolidated and same facility inpatient surgeries declined 2.2% and 2.3%, respectively, in the first quarter of 2011, compared to the first quarter of 2010. Consolidated and same facility emergency department visits increased 11.7% and 11.3%, respectively, during the quarter ended March 31, 2011, compared to the quarter ended March 31, 2010.

Salaries and benefits, as a percentage of revenues, were 40.9% in the first quarter of 2011 and 40.7% in the first quarter of 2010. Salaries and benefits, as a percentage of cash revenues, were 44.5% in the first quarter of 2011 and 44.0% in the first quarter of 2010. Salaries and benefits per equivalent admission increased 3.4% in the first quarter of 2011 compared to the first quarter of 2010. Same facility labor rate increases averaged 2.9% for the first quarter of 2011 compared to the first quarter of 2010.

Supplies, as a percentage of revenues, were 15.8% in the first quarter of 2011 and 15.9% in the first quarter of 2010. Supplies, as a percentage of cash revenues, were 17.2% in both the first quarters of 2011 and 2010. Supply cost per equivalent admission increased 2.5% in the first quarter of 2011 compared to the first quarter of 2010. Supply costs per equivalent admission increased 0.8% for pharmacy supplies and 5.5% for general medical and surgical items and declined 1.0% for medical devices and 0.8% for blood products in the first quarter of 2011 compared to the first quarter of 2010.

Other operating expenses, as a percentage of revenues, increased to 16.4% in the first quarter of 2011 from 15.9% in the first quarter of 2010. Other operating expenses, as a percentage of cash revenues, increased to 17.8% in the first quarter of 2011 from 17.3% in the first quarter of 2010. Other operating expenses is primarily comprised of contract services, professional fees, repairs and maintenance, rents and leases, utilities, insurance (including professional liability insurance) and nonincome taxes. Other operating expenses include $91 million and $90 million of indigent care costs in certain Texas markets during the first quarters of 2011 and 2010, respectively. Provisions for losses related to professional liability risks were $61 million and $56 million for the first quarters of 2011 and 2010, respectively.

Provision for doubtful accounts increased $85 million from $564 million in the first quarter of 2010 to $649 million in the first quarter of 2011, and as a percentage of revenues, increased to 8.1% in the first quarter of 2011 from 7.5% in the first quarter of 2010. The provision for doubtful accounts and the allowance for doubtful accounts relate primarily to uninsured amounts due directly from patients. The combined self-pay revenue deductions for charity care and uninsured discounts increased $328 million during the first quarter of 2011, compared to the first quarter of 2010. The sum of the provision for doubtful accounts, uninsured discounts and charity care, as a percentage of the sum of revenues, uninsured discounts and charity care, was 25.7% for the first quarter of 2011, compared to 23.5% for the first quarter of 2010. To quantify the total impact of and trends related to uninsured accounts, we believe it is beneficial to review the related revenue deductions and the provision for doubtful accounts in combination, rather than separately. At March 31, 2011, our allowance for doubtful accounts

33

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)

Results of Operations (continued)

Quarters Ended March 31, 2011 and 2010 (continued)

represented approximately 93% of the $4.179 billion total patient due accounts receivable balance. The patient due accounts receivable balance represents the estimated uninsured portion of our accounts receivable.

Equity in earnings of affiliates was $76 million and $68 million in the first quarters of 2011 and 2010, respectively. Equity in earnings of affiliates relates primarily to our Denver, Colorado market joint venture.

Depreciation and amortization increased $3 million, from $355 million in the first quarter of 2010 to $358 million in the first quarter of 2011.

Interest expense increased from $516 million in the first quarter of 2010 to $533 million in the first quarter of 2011 due primarily to an increase in the average debt balance. Our average debt balance was $27.357 billion for the first quarter of 2011 compared to $26.314 billion for the first quarter of 2010. The average effective interest rate for our long term debt declined from 8.0% for the quarter ended March 31, 2010 to 7.9% for the quarter ended March 31, 2011.

During the first quarter of 2011, we recorded net losses on sales of facilities of $1 million. During the first quarter of 2010, no gains or losses on sales of facilities were recognized.

During the first quarter of 2010, we recorded impairments of long-lived assets of $18 million to adjust the value of certain real estate investments to estimated fair value. There were no impairments of long-lived assets during the first quarter of 2011.

Our Investors have provided management and advisory services to the Company, pursuant to a management agreement among HCA and the Investors executed in connection with the Investors’ acquisition of HCA in November 2006. In March 2011, the management agreement was terminated pursuant to its terms upon completion of the initial public offering of our common stock, and the Investors were paid a final fee of $181 million.

The effective tax rates were 43.3% and 35.0% for the first quarters of 2011 and 2010, respectively. The effective tax rate computations exclude net income attributable to noncontrolling interests as it relates to consolidated partnerships. Our provision for income taxes for the first quarters of 2011 and 2010 increased and declined by $29 million and $7 million, respectively, related to adjustments to our liability for unrecognized tax benefits. Excluding the effect of these adjustments, the effective tax rates for the first quarters of 2011 and 2010 would have been 36.4% and 36.2%, respectively.

Net income attributable to noncontrolling interests increased from $88 million for the first quarter of 2010 to $94 million for the first quarter of 2011. The increase in net income attributable to noncontrolling interests related primarily to growth in operating results of a hospital joint venture in a Texas market.

Liquidity and Capital Resources

Cash provided by operating activities totaled $918 million in the first quarter of 2011 compared to $859 million in the first quarter of 2010. The $59 million increase in cash provided by operating activities in the first quarter of 2011 compared to the first quarter of 2010 related primarily to the combined impact of positive cash flows from changes in working capital items and income tax refunds exceeding the decline in net income, which was primarily due to the termination of management agreement charge. The combined interest payments and net tax refunds in the first quarters of 2011 and 2010 were $241 million and $303 million, respectively. Working capital totaled $2.719 billion at March 31, 2011 and $2.650 billion at December 31, 2010.

Cash used in investing activities was $273 million in the first quarter of 2011 compared to $181 million in the first quarter of 2010. Excluding acquisitions, capital expenditures were $329 million in the first quarter of 2011 and $214 million in the first quarter of 2010. We expended $22 million and $21 million for acquisitions of nonhospital health care facilities during the first quarters of 2011 and 2010, respectively. Capital expenditures are expected to approximate $1.550 billion in 2011. At March 31, 2011, there were projects under construction which had estimated

34

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)

Liquidity and Capital Resources (continued)

additional costs to complete and equip over the next five years of approximately $1.690 billion. We expect to finance capital expenditures with internally generated and borrowed funds. We received $55 million and $24 million from sales of hospitals and health care entities during the first quarters of 2011 and 2010, respectively. We received net cash flows from our investments of $20 million and $29 million in the first quarters of 2011 and 2010, respectively.

Cash used in financing activities totaled $503 million during the first quarter of 2011 compared to $602 million during the first quarter of 2010. During the first quarter of 2011, net cash flows used in financing activities included reductions in net borrowings of $2.900 billion, net proceeds of $2.506 billion related to the issuance of common stock in conjunction with our initial public offering, distributions to noncontrolling interests of $95 million, distributions to stockholders of $30 million and receipts of $22 million of income tax benefits for certain items (primarily distributions to holders of our stock options). During the first quarter of 2010, cash flows used in financing activities included payment of a distribution to stockholders of $1.751 billion ($3.88 per common share), increases in net borrowings of $1.216 billion, distributions to noncontrolling interests of $83 million, payment of debt issuance costs of $25 million and receipts of $42 million of income tax benefits million for certain items (primarily distributions to holders of our stock options).

We are a highly leveraged company with significant debt service requirements. Our debt totaled $25.366 billion at March 31, 2011. Our interest expense was $533 million for the first quarter of 2011 and $516 million for the first quarter of 2010. The increase in interest expense is due primarily to an increase in the average debt balance.

In addition to cash flows from operations, available sources of capital include amounts available under our senior secured credit facilities ($3.917 billion and $3.866 billion available as of March 31, 2011 and April 30, 2011, respectively) and anticipated access to public and private debt markets.

On May 3, 2011, we called for redemption all $1.000 billion aggregate principal amount of our 91/8% Senior Secured Notes due 2014 (the “Second Lien Notes due 2014”). The Second Lien Notes due 2014 will be redeemed on June 2, 2011 at a redemption price of 104.563% of the principal amount. On May 3, 2011, we also called for redemption $108.5 million aggregate principal amount of our 97/8% Senior Secured Notes due 2017 (the “Second Lien Notes due 2017”). The Second Lien Notes due 2017 will be redeemed on June 2, 2011 at a redemption price of 109.875% of the principal amount. The pretax debt extinguishment charge related to the redemptions is expected to be approximately $75 million.

On May 4, 2011, we completed amendments to our senior secured credit agreement and senior secured asset-based revolving credit agreement, as well as extensions of certain of our term loans. The amendments extend approximately $594 million of our term loan A facility with a final maturity of November 2012 to a final maturity of May 2016 and approximately $2.373 billion of our term loan A and term loan B-1 facilities with final maturities of November 2012 and November 2013, respectively, to a final maturity of May 2018.

Investments of our professional liability insurance subsidiary, to maintain statutory equity and pay claims, totaled $706 million and $742 million at March 31, 2011 and December 31, 2010, respectively. The insurance subsidiary maintained net reserves for professional liability risks of $432 million and $452 million at March 31, 2011 and December 31, 2010, respectively. Our facilities are insured by our wholly-owned insurance subsidiary for losses up to $50 million per occurrence; however, this coverage is subject to a $5 million per occurrence self-insured retention. Net reserves for the self-insured professional liability risks retained were $819 million and $796 million at March 31, 2011 and December 31, 2010, respectively. Claims payments, net of reinsurance recoveries, during the next 12 months are expected to approximate $270 million. We estimate that approximately $172 million of the expected net claim payments during the next 12 months will relate to claims in the self-insured retention.

Management believes that cash flows from operations, amounts available under our senior secured credit facilities and our anticipated access to public and private debt markets will be sufficient to meet expected liquidity needs during the next twelve months.

35

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)

Liquidity and Capital Resources (continued)

Market Risk

We are exposed to market risk related to changes in market values of securities. The investments in debt and equity securities of our wholly-owned insurance subsidiary were $698 million and $8 million, respectively, at March 31, 2011. These investments are carried at fair value, with changes in unrealized gains and losses being recorded as adjustments to other comprehensive income. At March 31, 2011, we had a net unrealized gain of $8 million on the insurance subsidiary’s investment securities.

We are exposed to market risk related to market illiquidity. Liquidity of the investments in debt and equity securities of our wholly-owned insurance subsidiary could be impaired by the inability to access the capital markets. Should the wholly-owned insurance subsidiary require significant amounts of cash in excess of normal cash requirements to pay claims and other expenses on short notice, we may have difficulty selling these investments in a timely manner or be forced to sell them at a price less than what we might otherwise have been able to in a normal market environment. At March 31, 2011, our wholly-owned insurance subsidiary had invested $169 million ($170 million par value) in tax-exempt student loan auction rate securities that continue to experience market illiquidity. It is uncertain if auction-related market liquidity will resume for these securities. We may be required to recognize other-than-temporary impairments on these long-term investments in future periods should issuers default on interest payments or should the fair market valuations of the securities deteriorate due to ratings downgrades or other issue specific factors.

We are also exposed to market risk related to changes in interest rates, and we periodically enter into interest rate swap agreements to manage our exposure to these fluctuations. Our interest rate swap agreements involve the exchange of fixed and variable rate interest payments between two parties, based on common notional principal amounts and maturity dates. The notional amounts of the swap agreements represent balances used to calculate the exchange of cash flows and are not our assets or liabilities. Our credit risk related to these agreements is considered low because the swap agreements are with creditworthy financial institutions. The interest payments under these agreements are settled on a net basis. These derivatives have been recognized in the financial statements at their respective fair values. Changes in the fair value of these derivatives, which are designated as cash flow hedges, are included in other comprehensive income, and changes in the fair value of derivatives which have not been designated as hedges are recorded in operations.

With respect to our interest-bearing liabilities, approximately $456 million of long-term debt at March 31, 2011 was subject to variable rates of interest, while the remaining balance in long-term debt of $24.910 billion at March 31, 2011 was subject to fixed rates of interest. Both the general level of interest rates and, for the senior secured credit facilities, our leverage affect our variable interest rates. Our variable debt is comprised primarily of amounts outstanding under the senior secured credit facilities. Borrowings under the senior secured credit facilities bear interest at a rate equal to an applicable margin plus, at our option, either (a) a base rate determined by reference to the higher of (1) the federal funds rate plus 0.50% and (2) the prime rate of Bank of America or (b) a LIBOR rate for the currency of such borrowing for the relevant interest period. The applicable margin for borrowings under the senior secured credit facilities may fluctuate according to a leverage ratio. The average effective interest rate for our long-term debt declined from 8.0% for the quarter ended March 31, 2010 to 7.9% for the quarter ended March 31, 2011.

The estimated fair value of our total long-term debt was $26.395 billion at March 31, 2011. The estimates of fair value are based upon the quoted market prices for the same or similar issues of long-term debt with the same maturities. Based on a hypothetical 1% increase in interest rates, the potential annualized reduction to future pretax earnings would be approximately $5 million. To mitigate the impact of fluctuations in interest rates, we generally target a portion of our debt portfolio to be maintained at fixed rates.

Our international operations and foreign currency denominated loans expose us to market risks associated with foreign currencies. In order to mitigate the currency exposure related to foreign currency denominated debt service

36

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)

Liquidity and Capital Resources (continued)

Market Risk (continued)

obligations, we have entered into cross currency swap agreements. A cross currency swap is an agreement between two parties to exchange a stream of principal and interest payments in one currency for a stream of principal and interest payments in another currency over a specified period. Our credit risk related to these agreements is considered low because the swap agreements are with creditworthy financial institutions.

Pending IRS Disputes

At March 31, 2011, we were contesting, before the IRS Appeals Division, certain claimed deficiencies and adjustments proposed by the IRS Examination Division in connection with its audit of HCA Inc.’s 2005 and 2006 federal income tax returns. The disputed items include the timing of recognition of certain patient service revenues, the deductibility of certain debt retirement costs and our method for calculating the tax allowance for doubtful accounts. In addition, eight taxable periods of HCA Inc. and its predecessors ended in 1997 through 2004, for which the primary remaining issue is the computation of the tax allowance for doubtful accounts, were pending before the IRS Examination Division as of March 31, 2011. The IRS Examination Division began an audit of HCA Inc.’s 2007, 2008 and 2009 federal income tax returns in 2010.

Management believes that HCA, its predecessors, subsidiaries and affiliates properly reported taxable income and paid taxes in accordance with applicable laws and agreements established with the IRS and that final resolution of these disputes will not have a material, adverse effect on our results of operations or financial position. However, if payments due upon final resolution of these issues exceed our recorded estimates, such resolutions could have a material, adverse effect on our results of operations or financial position.

37

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)

Operating Data

	2011		2010
CONSOLIDATING
Number of hospitals in operation at:
March 31		156		154
June 30				154
September 30				154
December 31				156
Number of freestanding outpatient surgical centers in operation at:
March 31		98		98
June 30				98
September 30				96
December 31				97
Licensed hospital beds at(a):
March 31		39,075		38,719
June 30				38,636
September 30				38,636
December 31				38,827
Weighted average licensed beds(b):
Quarter:
First		39,061		38,687
Second				38,607
Third				38,645
Fourth				38,680
Year				38,655
Average daily census(c):
Quarter:
First		22,002		21,696
Second				20,418
Third				19,848
Fourth				20,155
Year				20,523
Admissions(d):
Quarter:
First		406,900		398,900
Second				385,200
Third				383,800
Fourth				386,500
Year				1,554,400

38

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)

Operating Data — (Continued)

	2011		2010
Equivalent admissions(e):
Quarter:
First		638,400		615,500
Second				617,900
Third				617,700
Fourth				617,300
Year				2,468,400
Average length of stay (days)(f):
Quarter:
First		4.9		4.9
Second				4.8
Third				4.8
Fourth				4.8
Year				4.8
Emergency room visits(g):
Quarter:
First		1,527,600		1,367,100
Second				1,436,200
Third				1,457,100
Fourth				1,445,800
Year				5,706,200
Outpatient surgeries(h):
Quarter:
First		193,000		190,700
Second				198,600
Third				194,100
Fourth				200,200
Year				783,600
Inpatient surgeries(i):
Quarter:
First		119,700		122,500
Second				121,800
Third				121,600
Fourth				121,200
Year				487,100

39

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)

Operating Data — (Continued)

	2011			2010
Days revenues in accounts receivable(j):
Quarter:
First		45			46
Second					44
Third					44
Fourth					46
Year					46
Gross patient revenues(k) (dollars in millions):
Quarter:
First	$	34,764		$	31,054
Second					30,731
Third					30,647
Fourth					33,208
Year					125,640
Outpatient revenues as a % of patient revenues(l):
Quarter:
First		38	%		36	%
Second					38	%
Third					38	%
Fourth					38	%
Year					38	%
NONCONSOLIDATING(m)
Number of hospitals in operation at:
March 31		7			8
June 30					8
September 30					8
December 31					8
Number of freestanding outpatient surgical centers in operation at:
March 31		9			8
June 30					8
September 30					8
December 31					9
Licensed hospital beds at:
March 31		2,259			2,369
June 30					2,369
September 30					2,369
December 31					2,369

40

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)

Operating Data — (Continued)

BALANCE SHEET DATA

	% of Accounts Receivable
	Under 91 Days			91 — 180 Days			Over 180 Days
Accounts receivable aging at March 31, 2011(n):
Medicare and Medicaid		14	%		1	%		1	%
Managed care and other discounted		23			4			5
Uninsured		16			8			28
Total		53	%		13	%		34	%

(a)	Licensed beds are those beds for which a facility has been granted approval to operate from the applicable state licensing agency.
(b)	Represents the average number of licensed beds, weighted based on periods owned.
(c)	Represents the average number of patients in our hospital beds each day.
(d)	Represents the total number of patients admitted to our hospitals and is used by management and certain investors as a general measure of inpatient volume.
(e)	Equivalent admissions are used by management and certain investors as a general measure of combined inpatient and outpatient volume. Equivalent admissions are computed by multiplying admissions (inpatient volume) by the sum of gross inpatient revenues and gross outpatient revenues and then dividing the resulting amount by gross inpatient revenues. The equivalent admissions computation “equates” outpatient revenues to the volume measure (admissions) used to measure inpatient volume resulting in a general measure of combined inpatient and outpatient volume.
(f)	Represents the average number of days admitted patients stay in our hospitals.
(g)	Represents the number of patients treated in our emergency rooms.
(h)	Represents the number of surgeries performed on patients who were not admitted to our hospitals. Pain management and endoscopy procedures are not included in outpatient surgeries.
(i)	Represents the number of surgeries performed on patients who have been admitted to our hospitals. Pain management and endoscopy procedures are not included in inpatient surgeries.

(j) Revenues per day is calculated by dividing the revenues for the period by the days in the period. Days revenues in accounts receivable is then calculated as accounts receivable, net of allowance for doubtful accounts, at the end of the period divided by the revenues per day.

(k)	Gross patient revenues are based upon our standard charge listing. Gross charges/revenues typically do not reflect what our hospital facilities are paid. Gross charges/revenues are reduced by contractual adjustments, discounts and charity care to determine reported revenues.
(l)	Represents the percentage of patient revenues related to patients who are not admitted to our hospitals.
(m)	The nonconsolidating facilities include facilities operated through 50/50 joint ventures which we do not control and are accounted for using the equity method of accounting.

(n) Accounts receivable aging data is based upon consolidated gross accounts receivable of $7.930 billion (each 1% is equivalent to approximately $79 million of gross accounts receivable).

41

ITEM 3.   QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

The information called for by this item is provided under the caption “Market Risk” under Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

ITEM 4.   CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

HCA’s chief executive officer and chief financial officer have reviewed and evaluated the effectiveness of HCA’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) promulgated under the Securities Exchange Act of 1934 (the “Exchange Act”)) as of the end of the period covered by this quarterly report. Based on that evaluation, the chief executive officer and chief financial officer have concluded HCA’s disclosure controls and procedures effectively and timely provide them with material information relating to HCA and its consolidated subsidiaries required to be disclosed in the reports HCA files or submits under the Exchange Act.

Changes in Internal Control Over Financial Reporting

During the period covered by this report, there have been no changes in our internal control over financial reporting that have materially affected or are reasonably likely to materially affect our internal control over financial reporting.

Part II: Other Information

Item 1:   Legal Proceedings

We operate in a highly regulated and litigious industry. As a result, various lawsuits, claims and legal and regulatory proceedings have been and can be expected to be instituted or asserted against us. The resolution of any such lawsuits, claims or legal and regulatory proceedings could materially and adversely affect our results of operations and financial position in a given period.

Government Investigations, Claims and Litigation

Health care companies are subject to numerous investigations by various governmental agencies. Further, under the federal False Claims Act, private parties have the right to bring qui tam, or “whistleblower,” suits against companies that submit false claims for payments to, or improperly retain overpayments from, the government. Some states have adopted similar state whistleblower and false claims provisions. Certain of our individual facilities have received government inquiries from federal and state agencies and our facilities may receive such inquiries in future periods. Depending on whether the underlying conduct in these or future inquiries or investigations could be considered systemic, their resolution could have a material, adverse effect on our results of operations or financial position.

The Civil Division of the Department of Justice (“DOJ”) has contacted the Company in connection with its nationwide review of whether, in certain cases, hospital charges to the federal government relating to implantable cardio-defibrillators (“ICDs”) met the Centers for Medicare & Medicaid Services (“CMS”) criteria. In connection with this nationwide review, the DOJ has indicated that it will be reviewing certain ICD billing and medical records at 87 HCA hospitals; the review covers the period from October 2003 to the present. The review could potentially give rise to claims against the Company under the federal False Claims Act or other statutes, regulations or laws. At this time, we cannot predict what effect, if any, this review or any resulting claims could have on the Company.

New Hampshire Hospital Litigation

In 2006, the Foundation for Seacoast Health (the “Foundation”) filed suit against HCA in state court in New Hampshire. The Foundation alleged that both the 2006 recapitalization transaction and a prior 1999 intra-corporate transaction violated a 1983 agreement that placed certain restrictions on transfers of the Portsmouth Regional Hospital. In May 2007, the trial court ruled against the Foundation on all its claims. On appeal, the New Hampshire Supreme Court affirmed the ruling on the 2006 recapitalization, but remanded to the trial court the

42

claims based on the 1999 intra-corporate transaction. The trial court ruled in December 2009 that the 1999 intra-corporate transaction breached the transfer restriction provisions of the 1983 agreement. The court will now conduct additional proceedings to determine whether any harm has flowed from the alleged breach, and if so, what the appropriate remedy should be. The court may consider whether to, among other things, award monetary damages, rescind or undo the 1999 intra-corporate transfer or give the Foundation a right to purchase hospital assets at a price to be determined (which the Foundation asserts should be below the fair market value of the hospital). Trial for the remedies phase began on May 2, 2011 and is ongoing.

General Liability and Other Claims

We are a party to certain proceedings relating to claims for income taxes and related interest before the IRS Appeals Division. For a description of those proceedings, see Part I, Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Pending IRS Disputes” and Note 2 to our condensed consolidated financial statements.

We are also subject to claims and suits arising in the ordinary course of business, including claims for personal injuries or for wrongful restriction of, or interference with, physicians’ staff privileges. In certain of these actions the claimants have asked for punitive damages against us, which may not be covered by insurance. In the opinion of management, the ultimate resolution of these pending claims and legal proceedings will not have a material, adverse effect on our results of operations or financial position.

Item 1A:   Risk Factors

Reference is made to the factors set forth under the caption “Forward-Looking Statements” in Part I, Item 2 of this Form 10-Q and other risk factors described in our annual report on Form 10-K for the year ended December 31, 2010, which are incorporated herein by reference. There have not been any material changes to the risk factors previously disclosed in our annual report on Form 10-K for the year ended December 31, 2010, except as set forth below.

Changes in government health care programs may reduce our revenues.

A significant portion of our patient volume is derived from government health care programs, principally Medicare and Medicaid. Specifically, we derived approximately 41% of our revenues from the Medicare and Medicaid programs in 2010. Changes in government health care programs may reduce the reimbursement we receive and could adversely affect our business and results of operations.

In recent years, legislative and regulatory changes have resulted in limitations on and, in some cases, reductions in levels of payments to health care providers for certain services under the Medicare program. For example, CMS completed a two-year transition to full implementation of the Medicare severity diagnosis-related group (“MS-DRG”) system, which represents a refinement to the existing diagnosis-related group system. Future realignments in the MS-DRG system could impact the margins we receive for certain services. Further, the Health Reform Law provides for material reductions in the growth of Medicare program spending, including reductions in Medicare market basket updates and Medicare disproportionate share hospital (“DSH”) funding. Medicare payments in federal fiscal year 2011 for inpatient hospital services are expected to be slightly lower than payments for the same services in federal fiscal year 2010, because of reductions resulting from the Health Reform Law and the MS-DRG implementation. CMS has issued a proposed rule that, if implemented, would result in a slight decrease to Medicare reimbursement for inpatient hospital services in fiscal year 2012 compared to fiscal year 2011.

Since most states must operate with balanced budgets and since the Medicaid program is often a state’s largest program, some states can be expected to enact or consider enacting legislation designed to reduce their Medicaid expenditures. The current economic downturn has increased the budgetary pressures on many states, and these budgetary pressures have resulted, and likely will continue to result, in decreased spending, or decreased spending growth, for Medicaid programs and the Children’s Health Insurance Program in many states. For example, in May 2011, the Florida legislature announced a budget agreement for the fiscal year beginning July 1, 2011 that would reduce Medicaid reimbursements to hospitals. If this reduction is signed into law, we estimate that Florida Medicaid payments to our hospitals may be reduced by approximately $25 million dollars in the second half of calendar year

43

2011 and by another approximately $25 million in the first half of calendar year 2012. The Health Reform Law provides for material reductions to Medicaid DSH funding. Further, many states have also adopted, or are considering, legislation designed to reduce coverage, enroll Medicaid recipients in managed care programs and/or impose additional taxes on hospitals to help finance or expand the states’ Medicaid systems. Effective March 23, 2010, the Health Reform Law requires states to at least maintain Medicaid eligibility standards established prior to the enactment of the law for adults until January 1, 2014 and for children until October 1, 2019. However, states with budget deficits may seek a waiver from this requirement to address eligibility standards that apply to adults making more than 133% of the federal poverty level. The Health Reform Law also provides for significant expansions to the Medicaid program, but these changes are not required until 2014. In addition, the Health Reform Law will result in increased state legislative and regulatory changes in order for states to comply with new federal mandates, such as the requirement to establish Exchanges, and to participate in grants and other incentive opportunities.

In some cases, commercial third-party payers rely on all or portions of the MS-DRG system to determine payment rates, which may result in decreased reimbursement from some commercial third-party payers. Other changes to government health care programs may negatively impact payments from commercial third-party payers.

Current or future health care reform efforts, changes in laws or regulations regarding government health care programs, other changes in the administration of government health care programs and changes to commercial third-party payers in response to health care reform and other changes to government health care programs could have a material, adverse effect on our financial position and results of operations.

Item 2:   Unregistered Sales of Equity Securities and Use of Proceeds

During the first quarter of 2011, we issued and sold 457,027 shares of common stock in connection with the cashless exercise of stock options for aggregate consideration of $1,293,478 resulting in 277,427 net settled shares. We also issued and sold 10,879 shares of common stock in connection with the cash exercise of stock options for aggregate consideration of $30,791. The shares were issued without registration in reliance on the exemptions afforded by Section 4(2) of the Securities Act of 1933, as amended, and Rule 701 promulgated thereunder.

Use of Proceeds from Registered Securities

On March 15, 2011, we completed an initial public offering covered by the Registration Statement on Form S-1 (File No. 333-171369) of 145,130,000 shares of common stock, including the exercise in full by the underwriters of their option to purchase additional shares, for cash consideration of $30.00 per share ($28.9125 per share, net of underwriting discounts) to a syndicate of underwriters led by Merrill Lynch, Pierce, Fenner & Smith Incorporated, Citigroup Global Markets Inc., J.P. Morgan Securities LLC, Barclays Capital Inc., Credit Suisse Securities (USA) LLC, Deutsche Bank Securities Inc., Goldman, Sachs & Co., Morgan Stanley & Co. Incorporated and Wells Fargo Securities, LLC. We sold 87,719,300 shares for approximately $2.5 billion in net proceeds before expenses, and the selling stockholders sold 57,410,700 shares for approximately $1.7 billion in net proceeds before expenses. We did not receive any proceeds from the shares sold by the selling stockholders. We incurred approximately $95 million in underwriter discounts and an estimated $33 million of fees and expenses in connection with our initial public offering, which included a $26 million fee paid to affiliates of each of Bain Capital Partners, Kohlberg Kravis Roberts & Co. and BAML Capital Partners (formerly Merrill Lynch Global Private Equity) and certain members of the Frist family, including Thomas F. Frist, Jr., M.D., Thomas F. Frist III and William R. Frist (the “Investors”), each of whom have an indirect interest in more than 10% of our capital stock through their investment in Hercules Holding II, LLC and certain members of whom serve on our board of directors, pursuant to a management agreement among HCA Inc. and the Investors. We also paid the Investors an additional final fee of $181 million in connection with the termination of the management agreement which occurred upon completion of the initial public offering of our common stock.

As contemplated in our Prospectus, dated March 9, 2011, filed pursuant to Rule 424(b) of the Securities Act of 1933, as amended, we used approximately $2.5 billion of the proceeds from our initial public offering to temporarily repay indebtedness outstanding under our revolving credit facilities, pending more permanent application of the proceeds.

44

Item 5:   Other Information

Our Bylaws were amended and restated as of March 9, 2011 in connection with the pricing of the initial public offering of our common stock, to, among other things, provide that stockholders seeking to nominate candidates for election as directors or to bring business before an annual or special meeting of stockholders must provide timely notice of their proposal in writing to the secretary of the Company. Generally, to be timely, a stockholder’s notice must be delivered to, mailed or received at our principal executive offices, addressed to the secretary of the Company, and within the following time periods:

•  in the case of an annual meeting, no earlier than 120 days and no later than 90 days prior to the first anniversary of the date of the preceding year’s annual meeting; provided, however, that if (A) the annual meeting is advanced by more than 30 days, or delayed by more than 60 days, from the first anniversary of the preceding year’s annual meeting, or (B) no annual meeting was held during the preceding year, to be timely the stockholder notice must be received no earlier than 120 days before such annual meeting and no later than the later of 90 days before such annual meeting or the tenth day after the day on which public disclosure of the date of such meeting is first made; and

•  in the case of a nomination of a person or persons for election to the Board of Directors at a special meeting of the stockholders called for the purpose of electing directors, no earlier than 120 days before such special meeting and no later than the later of 90 days before such annual or special meeting or the tenth day after the day on which public disclosure of the date of such meeting is first made.

In no event shall an adjournment, postponement or deferral, or public disclosure of an adjournment, postponement or deferral, of a meeting of the stockholders commence a new time period (or extend any time period) for the giving of the stockholder notice.

Item 6:   Exhibits

(a) List of Exhibits:

3.1	—	Amended and Restated Certificate of Incorporation of the Company (filed as Exhibit 3.1 to the Company’s Registration Statement on Form S-1 (File No. 333-171369), and incorporated herein by reference).
3.2	—	Amended and Restated Bylaws of the Company (filed as Exhibit 3.2 to the Company’s Registration Statement on Form S-1 (File No. 333-171369), and incorporated herein by reference).
10.1	—	HCA Holdings, Inc. 2011 Senior Officer Performance Excellence Program (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed April 5, 2011, and incorporated herein by reference).*
10.2	—	Form of 2011 PEP Restricted Share Unit Agreement (Officers) (filed as Exhibit 10.2 to the Company’s Current Report on Form 8-K filed April 5, 2011, and incorporated herein by reference).*
10.3	—	Stockholders’ Agreement, dated as of March 9, 2011, by and among the Company, Hercules Holding II, LLC and the other signatories thereto (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed March 16, 2011, and incorporated herein by reference).
10.4	—	2006 Stock Incentive Plan for Key Employees of HCA Holdings, Inc. and its Affiliates, as Amended and Restated (filed as Exhibit 10.11(b) to the Company’s Registration Statement on Form S-1 (File No. 333-171369), and incorporated herein by reference).*
10.5	—	Form of Director Restricted Share Unit Agreement Under the 2006 Stock Incentive Plan for Key Employees of HCA Holdings, Inc. and its Affiliates, as Amended and Restated.*
10.6	—	Form of Amendment to the Amended and Restated Limited Liability Company Agreement of Hercules Holding II, LLC (filed as Exhibit 10.32(a) to the Company’s Registration Statement on Form S-1 (File No. 333-171369), and incorporated herein by reference).
10.7	—	Form of Omnibus Amendment to HCA Holdings, Inc’s Management Stockholder’s Agreements (filed as Exhibit 10.39 to the Company’s Registration Statement on Form S-1 (File No. 333-171369), and incorporated herein by reference).
10.8	—	Amendment No. 2 to Employment Agreement effective February 9, 2011 (Richard M. Bracken) (filed as Exhibit 10.29(h) to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2010, and incorporated herein by reference).*

45

10.9	—	Amendment to Employment Agreement effective February 9, 2011 (R. Milton Johnson) (filed as Exhibit 10.29(i) to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2010, and incorporated herein by reference).*
10.10	—	Amendment to Employment Agreement effective February 9, 2011 (Samuel N. Hazen) (filed as Exhibit 10.29(j) to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2010, and incorporated herein by reference).*
10.11	—	Amendment to Employment Agreement effective February 9, 2011 (Beverly B. Wallace) (filed as Exhibit 10.29(k) to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2010, and incorporated herein by reference).*
10.12	—	Omnibus Amendment to Stock Option Agreements Issued Under the 2006 Stock Incentive Plan for Key Employees of HCA Holdings, Inc. and its Affiliates, as amended, effective February 16, 2011 (filed as Exhibit 10.38 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2010, and incorporated herein by reference).*
31.1	—	Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	—	Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32	—	Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of Sarbanes-Oxley Act of 2002.
101	—	The following financial information from our quarterly report on Form 10-Q for the quarter ended March 31, 2011, filed with the SEC on May 11, 2011, formatted in Extensible Business Reporting Language (XBRL): (i) the condensed consolidated balance sheets at March 31, 2011 and December 31, 2010, (ii) the condensed consolidated income statements for the quarters ended March 31, 2011 and 2010, (iii) the condensed consolidated statements of cash flows for the quarters ended March 31, 2011 and 2010, and (iv) the notes to condensed consolidated financial statements (tagged as blocks of text).(1)

(1)

The XBRL related information in Exhibit 101 to this quarterly report on Form 10-Q shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability of that section and shall not be incorporated by reference into any filing or other document pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing or document.

*

Management compensatory plan or arrangement.

46

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

HCA Holdings, Inc.

By:  /s/  R. Milton Johnson

R. Milton Johnson

President and Chief Financial Officer

Date: May 11, 2011

47

EX-10.5

Exhibit 10.5

HCA Holdings, Inc.
Restricted Share Unit Agreement
(Director)

     THIS RESTRICTED SHARE UNIT AGREEMENT (this “Agreement”) is made and entered into as of the ___ day of March, 2011 (the “Grant Date”), between HCA Holdings, Inc., a Delaware corporation (the “Company”), and [director], (the “Grantee”). Capitalized terms not otherwise defined herein shall have the meaning ascribed to such terms in the 2006 Stock Incentive Plan for Key Employees of HCA Holdings, Inc. and its Affiliates, as Amended and Restated (the “Plan”).

     WHEREAS, the Company has adopted the Plan, which permits the issuance of awards that are based on Shares of the Company, including the grant of a right to receive one Share at a specified date (or dates) in the future (a “Restricted Share Unit”); and

     WHEREAS, the Company has determined that a portion of the Grantee’s annual retainer for services as a director of the Company (a “Director”) should be paid to the Grantee in the form of Restricted Share Units, to be granted pursuant to the terms and conditions set forth in this award Agreement;

     NOW, THEREFORE, the parties hereto agree as follows:

     1. Grant of Restricted Share Unit Award.

          1.1 The Company hereby grants to the Grantee an award (“Award”) of [number] Restricted Share Units (“RSUs”) on the terms and conditions set forth in this Agreement and as otherwise provided in the Plan.

          1.2 The Grantee’s rights with respect to the Award shall remain forfeitable at all times prior to the dates on which the RSUs shall vest in accordance with Section 2 hereof. This Award may not be assigned, alienated, pledged, attached, sold or otherwise transferred or encumbered by Grantee other than by will or the laws of descent and distribution.

     2. Vesting and Payment.

          2.1 Except as provided in Section 2.2, the Award shall vest __________________________, so long as the Grantee continues to serve on the Board through such date (such _________ period sometimes referred to as the “Restricted Period”).

          2.2 Notwithstanding Section 2.1 above, all RSUs covered by the Award shall immediately vest upon the occurrence of a Change in Control that occurs prior to the expiration of the Restricted Period. If the Grantee’s service as a Director is terminated for any reason other than death or Disability, the Grantee shall forfeit all rights with respect to all RSUs that are not vested on such date; provided, however, if such termination is with Cause (as defined below), all RSUs whether vested or unvested shall immediately become void and of no effect. If the Grantee’s service as a Director is terminated by death or Disability, the RSUs covered by the Award shall immediately vest, but only in proportion to the length of the Director’s service as a director during such Restricted Period. For purposes of this Agreement, Cause shall mean the reasons for which a Director can be removed from the Board by the Company pursuant to the governing documents of the Company (including, without limitation, the Company’s by-laws and charter). For purposes of this Agreement, “Disability” shall mean that the Grantee is unable to perform the essential duties of a Director. Notwithstanding the foregoing, this provision is subject in its entirety to Section 9 of the Plan.

          2.3 The Grantee shall be entitled to payment in respect of all RSUs covered by the Award upon the vesting of such RSUs. Subject to the provisions of the Plan, such payment shall be made through the issuance to the Grantee, as promptly as practicable thereafter (or to the executors or administrators of Grantee’s estate, as promptly as practicable after the Company’s receipt of notification of Grantee’s death, as the case may be), of a number of Shares equal to the number of such vested RSUs. Notwithstanding the foregoing, if the Grantee shall have elected to defer payment of such vested RSUs to such later date as may be permitted by the Company, in accordance with the requirements of Section 409A of the Code, by ______________________, 20___, payment of such vested RSUs shall instead be made on such later date (the “Deferral Election”).

     3. Dividend Equivalent Rights.

          In the event that the Grantee makes a Deferral Election with respect to the settlement of the vested RSUs, the Grantee shall receive Dividend Equivalent Rights in respect of any vested RSUs covered by this Award at the time of any payment of dividends to stockholders on Shares. The amount of any such Dividend Equivalent Right shall equal the amount that would be payable to the Grantee as a stockholder in respect of a number of Shares equal to the number of vested RSUs then credited to the Grantee hereunder. Any such Dividend Equivalent Right shall be paid in accordance with the Company’s payment practices as may be established from time to time and as of the date on which such dividend would have been payable in respect of such number of Shares. No Dividend Equivalent Rights shall be paid under any circumstances in respect of RSUs that are not vested.

     4. No Right to Continued Service.

          Nothing in this Agreement or the Plan shall be interpreted or construed to confer upon the Grantee any right to continue service as a member of the Board.

     5. Adjustments.

          Notwithstanding anything else contained in this Agreement, the RSUs granted hereunder and this Agreement shall be subject to adjustment, substitution or cancellation in accordance with the provisions of Sections 8 and 9 of the Plan.

     6. Grantee Bound by the Plan.

          This Agreement shall be construed in accordance and consistent with, and subject to, the terms of the Plan. The Grantee hereby acknowledges receipt of a copy of the Plan and agrees to be bound by all the terms and provisions thereof.

     7. Plan Governs.

          The terms of this Agreement are governed by the terms of the Plan, and in the case of any inconsistency between the terms of this Agreement and the terms of the Plan, the terms of the Plan shall govern.

     8. Modification of Agreement.

          Subject to the provisions of Section 3 of the Plan, this Agreement may be modified, amended, suspended or terminated, and any terms or conditions may be waived, but only by a written instrument executed by the parties hereto.

     9. Severability.

          If any provision of this Agreement is, or becomes, or is deemed to be invalid, illegal, or unenforceable in any jurisdiction or as to any Person or the Award, or would disqualify the Plan or Award under any laws deemed applicable by the Committee, such provision shall be construed or deemed amended to conform to the applicable laws, or if it cannot be construed or deemed amended without, in the determination of the Committee, materially altering the intent of the Plan or the Award, such provision shall be stricken as to such jurisdiction, Person or Award, and the remainder of the Plan and Award shall remain in full force and effect.

     10. Taxes.

          The Grantee shall be responsible for all taxes due in connection with the grant or vesting or any payment or transfer with respect to the RSUs and Shares payable hereunder.

     11. Governing Law.

          The validity, interpretation, construction and performance of this Agreement shall be governed by the laws of the State of Delaware without giving effect to the conflicts of law principles thereof, except to the extent that such laws are preempted by Federal law.

     12. Successors in Interest.

          This Agreement shall inure to the benefit of and be binding upon any successor to the Company. This Agreement shall inure to the benefit of the Grantee’s legal representatives. All obligations imposed upon the Grantee and all rights granted to the Company under this Agreement shall be binding upon the Grantee’s heirs, executors, administrators and successors.

     13. Resolution of Disputes.

          Any dispute or disagreement which may arise under, or as a result of, or in any way related to, the interpretation, construction or application of this Agreement shall be determined by the Board. Any determination made hereunder shall be final, binding and conclusive on the Grantee and the Company for all purposes.

14. Entire Agreement.

          This Agreement and the Plan contain the entire agreement and understanding of the parties hereto with respect to the subject matter contained herein and supersede all prior communications, representations and negotiations in respect thereto.

HCA Holdings, Inc.

By:

Grantee:

Please Print

Grantee:

Signature

EX-31.1

EXHIBIT 31.1

CERTIFICATION

I, Richard M. Bracken, certify that:

     1. I have reviewed this quarterly report on Form 10-Q of HCA Holdings, Inc.;

     2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

     3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

     4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

     (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

     (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

     (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

     (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

     5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

     (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

     (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

By:	/s/ Richard M. Bracken
	Richard M. Bracken
	Chairman of the Board and Chief Executive Officer

Date: May 11, 2011

EX-31.2

EXHIBIT 31.2

CERTIFICATION

I, R. Milton Johnson, certify that:

     1. I have reviewed this quarterly report on Form 10-Q of HCA Holdings, Inc.;

     2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

     3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

     4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

     (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

     (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

     (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

     (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

     5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

     (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

     (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

By:	/s/ R. Milton Johnson
	R. Milton Johnson
	President and Chief Financial Officer

Date: May 11, 2011

EX-32

EXHIBIT 32

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection with the Quarterly Report of HCA Holdings, Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2011, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

     (1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

     (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

By:	/s/ Richard M. Bracken
	Richard M. Bracken
	Chairman of the Board and Chief Executive Officer

May 11, 2011

By:	/s/ R. Milton Johnson
	R. Milton Johnson
	President and Chief Financial Officer

May 11, 2011